{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "%%capture\n",
    "# !pip install unsloth\n",
    "# # Also get the latest nightly Unsloth!\n",
    "# !pip uninstall unsloth -y && pip install --upgrade --no-cache-dir --no-deps git+https://github.com/unslothai/unsloth.git"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ðŸ¦¥ Unsloth: Will patch your computer to enable 2x faster free finetuning.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-01-31 16:29:35.457056: I tensorflow/core/util/port.cc:153] oneDNN custom operations are on. You may see slightly different numerical results due to floating-point round-off errors from different computation orders. To turn them off, set the environment variable `TF_ENABLE_ONEDNN_OPTS=0`.\n",
      "2025-01-31 16:29:35.471455: E external/local_xla/xla/stream_executor/cuda/cuda_fft.cc:477] Unable to register cuFFT factory: Attempting to register factory for plugin cuFFT when one has already been registered\n",
      "WARNING: All log messages before absl::InitializeLog() is called are written to STDERR\n",
      "E0000 00:00:1738308575.488749 3245059 cuda_dnn.cc:8310] Unable to register cuDNN factory: Attempting to register factory for plugin cuDNN when one has already been registered\n",
      "E0000 00:00:1738308575.493957 3245059 cuda_blas.cc:1418] Unable to register cuBLAS factory: Attempting to register factory for plugin cuBLAS when one has already been registered\n",
      "2025-01-31 16:29:35.512069: I tensorflow/core/platform/cpu_feature_guard.cc:210] This TensorFlow binary is optimized to use available CPU instructions in performance-critical operations.\n",
      "To enable the following instructions: AVX2 AVX512F AVX512_VNNI FMA, in other operations, rebuild TensorFlow with the appropriate compiler flags.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unsloth: OpenAI failed to import - ignoring for now.\n",
      "ðŸ¦¥ Unsloth Zoo will now patch everything to make training faster!\n",
      "==((====))==  Unsloth 2024.12.4: Fast Llama patching. Transformers:4.46.3.\n",
      "   \\\\   /|    GPU: NVIDIA A100-PCIE-40GB. Max memory: 39.394 GB. Platform: Linux.\n",
      "O^O/ \\_/ \\    Torch: 2.5.0+cu124. CUDA: 8.0. CUDA Toolkit: 12.4. Triton: 3.1.0\n",
      "\\        /    Bfloat16 = TRUE. FA [Xformers = 0.0.28.post2. FA2 = True]\n",
      " \"-____-\"     Free Apache license: http://github.com/unslothai/unsloth\n",
      "Unsloth: Fast downloading is enabled - ignore downloading bars which are red colored!\n"
     ]
    }
   ],
   "source": [
    "from unsloth import FastLanguageModel\n",
    "import torch\n",
    "max_seq_length = 2048 # Choose any! We auto support RoPE Scaling internally!\n",
    "dtype = None # None for auto detection. Float16 for Tesla T4, V100, Bfloat16 for Ampere+\n",
    "load_in_4bit = True # Use 4bit quantization to reduce memory usage. Can be False.\n",
    "\n",
    "# 4bit pre quantized models we support for 4x faster downloading + no OOMs.\n",
    "fourbit_models = [\n",
    "    \"unsloth/Meta-Llama-3.1-8B-bnb-4bit\",      # Llama-3.1 15 trillion tokens model 2x faster!\n",
    "    \"unsloth/Meta-Llama-3.1-8B-Instruct-bnb-4bit\",\n",
    "    \"unsloth/Meta-Llama-3.1-70B-bnb-4bit\",\n",
    "    \"unsloth/Meta-Llama-3.1-405B-bnb-4bit\",    # We also uploaded 4bit for 405b!\n",
    "    \"unsloth/Mistral-Nemo-Base-2407-bnb-4bit\", # New Mistral 12b 2x faster!\n",
    "    \"unsloth/Mistral-Nemo-Instruct-2407-bnb-4bit\",\n",
    "    \"unsloth/mistral-7b-v0.3-bnb-4bit\",        # Mistral v3 2x faster!\n",
    "    \"unsloth/mistral-7b-instruct-v0.3-bnb-4bit\",\n",
    "    \"unsloth/Phi-3.5-mini-instruct\",           # Phi-3.5 2x faster!\n",
    "    \"unsloth/Phi-3-medium-4k-instruct\",\n",
    "    \"unsloth/gemma-2-9b-bnb-4bit\",\n",
    "    \"unsloth/gemma-2-27b-bnb-4bit\",            # Gemma 2x faster!\n",
    "] # More models at https://huggingface.co/unsloth\n",
    "\n",
    "model, tokenizer = FastLanguageModel.from_pretrained(\n",
    "    model_name = \"unsloth/Meta-Llama-3.1-8B\",\n",
    "    max_seq_length = max_seq_length,\n",
    "    dtype = dtype,\n",
    "    load_in_4bit = load_in_4bit,\n",
    "    # token = \"hf_...\", # use one if using gated models like meta-llama/Llama-2-7b-hf\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Unsloth: Dropout = 0 is supported for fast patching. You are using dropout = 0.05.\n",
      "Unsloth will patch all other layers, except LoRA matrices, causing a performance hit.\n",
      "Unsloth 2024.12.4 patched 32 layers with 0 QKV layers, 0 O layers and 0 MLP layers.\n"
     ]
    }
   ],
   "source": [
    "model = FastLanguageModel.get_peft_model(\n",
    "    model,\n",
    "    r = 8, # Choose any number > 0 ! Suggested 8, 16, 32, 64, 128\n",
    "    # target_modules = [\"q_proj\", \"k_proj\", \"v_proj\", \"o_proj\",\n",
    "    #                  \"gate_proj\", \"up_proj\", \"down_proj\",],\n",
    "    target_modules = [\"q_proj\", \"k_proj\", \"v_proj\"],\n",
    "    lora_alpha = 16,\n",
    "    lora_dropout = 0.05, # Supports any, but = 0 is optimized\n",
    "    bias = \"none\",    # Supports any, but = \"none\" is optimized\n",
    "    # [NEW] \"unsloth\" uses 30% less VRAM, fits 2x larger batch sizes!\n",
    "    use_gradient_checkpointing = \"unsloth\", # True or \"unsloth\" for very long context\n",
    "    random_state = 3407,\n",
    "    use_rslora = False,  # We support rank stabilized LoRA\n",
    "    loftq_config = None, # And LoftQ\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# from datasets import load_dataset\n",
    "# from datasets import Dataset, concatenate_datasets\n",
    "\n",
    "# import pandas as pd\n",
    "\n",
    "# alpaca_prompt = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
    "\n",
    "# ### Instruction:\n",
    "# {}\n",
    "\n",
    "# ### Input:\n",
    "# {}\n",
    "\n",
    "# ### Response:\n",
    "# {}\"\"\"\n",
    "\n",
    "# EOS_TOKEN = tokenizer.eos_token  # Must add EOS_TOKEN\n",
    "\n",
    "# def formatting_prompts_func(examples):\n",
    "#     instructions = examples[\"instruction\"]\n",
    "#     inputs = examples[\"input\"]\n",
    "#     outputs = examples[\"output\"]\n",
    "#     texts = []\n",
    "#     for instruction, input_text, output in zip(instructions, inputs, outputs):\n",
    "#         text = alpaca_prompt.format(instruction, input_text, output) + EOS_TOKEN\n",
    "#         texts.append(text)\n",
    "#     return { \"text\": texts }\n",
    "\n",
    "# dataset = load_dataset(\"passionMan/diabetes_v9\", split=\"train\")\n",
    "# dataset = dataset.map(formatting_prompts_func, batched=True)\n",
    "\n",
    "# dataset_df = pd.DataFrame(dataset)\n",
    "\n",
    "# long_data = dataset_df[dataset_df['dataset'].isin(['pubmedqa', 'icliniq', 'pubmed', 'chemdner', 'medal', 'mfc'])].reset_index(drop=True)\n",
    "# short_data = dataset_df[~dataset_df['dataset'].isin(['pubmedqa', 'icliniq', 'pubmed', 'chemdner', 'medal', 'mfc'])].reset_index(drop=True)\n",
    "\n",
    "# long_dataset = Dataset.from_pandas(long_data)\n",
    "# short_dataset = Dataset.from_pandas(short_data)\n",
    "\n",
    "# combined_dataset = concatenate_datasets([short_dataset, long_dataset])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2119145fdc8a46cabc562c4cbeb060f0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "README.md:   0%|          | 0.00/609 [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "6a4e752a6c6041fba87b916e47ac3ab8",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "train-00000-of-00001.parquet:   0%|          | 0.00/45.5M [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "579191cc9ef64032b9247c57bf9e455c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "test-00000-of-00001.parquet:   0%|          | 0.00/6.70M [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3cdc211d2ea04bf5811326c805143ec5",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Generating train split:   0%|          | 0/36809 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "de0f8cf631b348a58843d833ff582a0b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Generating test split:   0%|          | 0/6269 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "98b7d8732605497e924bb21c92dec8a4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Map:   0%|          | 0/36809 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "05d4ccb2cc4a45b58dc8157d0bea4e35",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Map:   0%|          | 0/8900 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ca6efa75b6834f658875b8bccb48450d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Map:   0%|          | 0/27909 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from datasets import load_dataset\n",
    "from datasets import Dataset, concatenate_datasets\n",
    "\n",
    "import pandas as pd\n",
    "\n",
    "alpaca_prompt = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
    "\n",
    "### Instruction:\n",
    "{}\n",
    "\n",
    "### Input:\n",
    "{}\n",
    "\n",
    "### Response:\n",
    "{}\"\"\"\n",
    "\n",
    "EOS_TOKEN = tokenizer.eos_token  # Must add EOS_TOKEN\n",
    "\n",
    "def formatting_prompts_func(examples):\n",
    "    instructions = examples[\"instruction\"]\n",
    "    inputs = examples[\"input\"]\n",
    "    outputs = examples[\"output\"]\n",
    "    texts = []\n",
    "    \n",
    "    for instruction, input_text, output in zip(instructions, inputs, outputs):\n",
    "        text = alpaca_prompt.format(instruction, input_text, output) + EOS_TOKEN\n",
    "        texts.append(text)\n",
    "\n",
    "    return { \"text\": texts }\n",
    "\n",
    "dataset = load_dataset(\"passionMan/diabetes_v11\", split=\"train\")\n",
    "dataset = dataset.map(formatting_prompts_func, batched=True)\n",
    "\n",
    "dataset_df = pd.DataFrame(dataset)\n",
    "\n",
    "long_data = dataset_df[dataset_df['dataset'].isin(['meddialog', 'pubmed', 'ddi'])].reset_index(drop=True)\n",
    "short_data = dataset_df[~dataset_df['dataset'].isin(['meddialog', 'pubmed', 'ddi'])].reset_index(drop=True)\n",
    "\n",
    "def tokenize_and_set_max_length(examples):\n",
    "    max_len = 4096 if examples[\"dataset\"] in ['meddialog', 'pubmed', 'ddi'] else 1024\n",
    "    return tokenizer(examples[\"text\"], truncation=True, padding=\"max_length\", max_length=max_len)\n",
    "\n",
    "long_dataset = Dataset.from_pandas(long_data).map(tokenize_and_set_max_length, batched=True)\n",
    "\n",
    "short_dataset = Dataset.from_pandas(short_data).map(tokenize_and_set_max_length, batched=True)\n",
    "\n",
    "combined_dataset = concatenate_datasets([short_dataset, long_dataset])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "# from trl import SFTTrainer\n",
    "# from transformers import TrainingArguments\n",
    "# from unsloth import is_bfloat16_supported\n",
    "# from datasets import Dataset, concatenate_datasets\n",
    "# import pandas as pd\n",
    "# import numpy as np\n",
    "\n",
    "\n",
    "# def compute_weights(example):\n",
    "#     return {\"weight\": 0.4 if example['dataset'] in ['pubmedqa', 'icliniq', 'pubmed', 'chemdner', 'medal', 'mfc'] else 0.6}\n",
    "\n",
    "# weighted_dataset = combined_dataset.map(compute_weights)\n",
    "\n",
    "# weights = np.array(weighted_dataset[\"weight\"])\n",
    "# weights = weights / weights.sum()  \n",
    "\n",
    "# weighted_indices = np.random.choice(len(combined_dataset), size=len(combined_dataset), p=weights)\n",
    "# resampled_dataset = combined_dataset.select(weighted_indices)\n",
    "\n",
    "# if isinstance(resampled_dataset, dict):\n",
    "#     resampled_dataset = Dataset.from_dict(resampled_dataset)\n",
    "\n",
    "# if \"text\" not in resampled_dataset.column_names:\n",
    "#     resampled_dataset = resampled_dataset.map(lambda x: {\"text\": x[\"input\"] + \" \" + x[\"output\"]})\n",
    "\n",
    "# trainer = SFTTrainer(\n",
    "#     model=model,\n",
    "#     tokenizer=tokenizer,\n",
    "#     train_dataset=resampled_dataset,\n",
    "#     dataset_text_field=\"text\",\n",
    "#     dataset_num_proc=16, \n",
    "\n",
    "#     args=TrainingArguments(\n",
    "#         per_device_train_batch_size=32, \n",
    "#         gradient_accumulation_steps=1,  \n",
    "#         warmup_steps=300,  \n",
    "#         num_train_epochs=3, \n",
    "#         learning_rate=3e-5,  \n",
    "#         fp16=not is_bfloat16_supported(),\n",
    "#         bf16=is_bfloat16_supported(),  \n",
    "#         optim=\"adamw_8bit\",  \n",
    "#         weight_decay=0.01,  \n",
    "#         lr_scheduler_type=\"linear\",  \n",
    "#         logging_steps=100,  \n",
    "#         seed=3407,  \n",
    "#         save_steps=200,  \n",
    "#         output_dir=\"outputs/weighted_sampling9\", \n",
    "#         report_to=\"none\",  \n",
    "#     ),\n",
    "# )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a1c2ee168342435eba6e3ca8378bd48f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Map:   0%|          | 0/36809 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n",
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n"
     ]
    }
   ],
   "source": [
    "from datasets import Dataset, concatenate_datasets\n",
    "import numpy as np\n",
    "from trl import SFTTrainer\n",
    "from transformers import TrainingArguments\n",
    "from unsloth import is_bfloat16_supported\n",
    "import pandas as pd\n",
    "\n",
    "def compute_weights(example):\n",
    "    if example['dataset'] in ['meddialog', 'pubmed']:\n",
    "        return {\"weight\": 0.6}\n",
    "    elif example['dataset'] in ['chemdner']:\n",
    "        return {\"weight\": 1.2} \n",
    "    else:\n",
    "        return {\"weight\": 1.0}\n",
    "\n",
    "\n",
    "if \"dataset\" in combined_dataset.column_names:\n",
    "    weighted_dataset = combined_dataset.map(compute_weights)\n",
    "else:\n",
    "    print(\"Warning: 'dataset' ì»¬ëŸ¼ì´ ì¡´ìž¬í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ê°€ì¤‘ì¹˜ ê³„ì‚°ì´ ë¶ˆê°€ëŠ¥í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\")\n",
    "\n",
    "weights = np.array(weighted_dataset[\"weight\"])\n",
    "weights = weights / weights.sum() \n",
    "\n",
    "weighted_indices = np.random.choice(len(combined_dataset), size=len(combined_dataset), p=weights)\n",
    "\n",
    "if \"__index_level_0__\" in combined_dataset.column_names:\n",
    "    combined_dataset = combined_dataset.remove_columns([\"__index_level_0__\"])\n",
    "\n",
    "resampled_dataset = combined_dataset.select(weighted_indices)\n",
    "\n",
    "if \"text\" not in resampled_dataset.column_names:\n",
    "    resampled_dataset = resampled_dataset.map(lambda x: {\"text\": x[\"input\"] + \" \" + x[\"output\"]})\n",
    "\n",
    "trainer = SFTTrainer(\n",
    "    model=model,\n",
    "    tokenizer=tokenizer,\n",
    "    train_dataset=resampled_dataset,\n",
    "    dataset_text_field=\"text\",\n",
    "    dataset_num_proc=16, \n",
    "\n",
    "    args=TrainingArguments(\n",
    "        per_device_train_batch_size=32, \n",
    "        gradient_accumulation_steps=1,  \n",
    "        warmup_steps=300,  \n",
    "        num_train_epochs=3, \n",
    "        learning_rate=3e-5,  \n",
    "        fp16=not is_bfloat16_supported(),\n",
    "        bf16=is_bfloat16_supported(),  \n",
    "        optim=\"adamw_8bit\",  \n",
    "        weight_decay=0.01,  \n",
    "        lr_scheduler_type=\"linear\",  \n",
    "        logging_steps=100,  \n",
    "        seed=3407,  \n",
    "        save_steps=200,  \n",
    "        output_dir=\"outputs/weighted_sampling11\", \n",
    "        report_to=\"none\",  \n",
    "    ),\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n",
      "==((====))==  Unsloth - 2x faster free finetuning | Num GPUs = 1\n",
      "   \\\\   /|    Num examples = 36,809 | Num Epochs = 3\n",
      "O^O/ \\_/ \\    Batch size per device = 32 | Gradient Accumulation steps = 1\n",
      "\\        /    Total batch size = 32 | Total steps = 3,453\n",
      " \"-____-\"     Number of trainable parameters = 4,718,592\n",
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n",
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n",
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "    <div>\n",
       "      \n",
       "      <progress value='2384' max='3453' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
       "      [2384/3453 6:34:01 < 2:56:49, 0.10 it/s, Epoch 2.07/3]\n",
       "    </div>\n",
       "    <table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       " <tr style=\"text-align: left;\">\n",
       "      <th>Step</th>\n",
       "      <th>Training Loss</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>100</td>\n",
       "      <td>2.135700</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>200</td>\n",
       "      <td>1.717700</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>300</td>\n",
       "      <td>1.351200</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>400</td>\n",
       "      <td>1.226100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>500</td>\n",
       "      <td>1.191000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>600</td>\n",
       "      <td>1.163900</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>700</td>\n",
       "      <td>1.146700</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>800</td>\n",
       "      <td>1.132200</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>900</td>\n",
       "      <td>1.132000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1000</td>\n",
       "      <td>1.094500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1100</td>\n",
       "      <td>1.120700</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1200</td>\n",
       "      <td>1.071500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1300</td>\n",
       "      <td>1.057200</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1400</td>\n",
       "      <td>1.073300</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1500</td>\n",
       "      <td>1.063700</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1600</td>\n",
       "      <td>1.087800</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1700</td>\n",
       "      <td>1.075400</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1800</td>\n",
       "      <td>1.095400</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1900</td>\n",
       "      <td>1.059300</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2000</td>\n",
       "      <td>1.089800</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2100</td>\n",
       "      <td>1.067100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2200</td>\n",
       "      <td>1.053600</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2300</td>\n",
       "      <td>1.052400</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table><p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "trainer_stats = trainer.train()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "## inference"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "from unsloth import FastLanguageModel\n",
    "import torch\n",
    "max_seq_length = 2048 # Choose any! We auto support RoPE Scaling internally!\n",
    "dtype = None # None for auto detection. Float16 for Tesla T4, V100, Bfloat16 for Ampere+\n",
    "load_in_4bit = True # Use 4bit quantization to reduce memory usage. Can be False.\n",
    "\n",
    "# 4bit pre quantized models we support for 4x faster downloading + no OOMs.\n",
    "fourbit_models = [\n",
    "    \"unsloth/Meta-Llama-3.1-8B-bnb-4bit\",      # Llama-3.1 15 trillion tokens model 2x faster!\n",
    "    \"unsloth/Meta-Llama-3.1-8B-Instruct-bnb-4bit\",\n",
    "    \"unsloth/Meta-Llama-3.1-70B-bnb-4bit\",\n",
    "    \"unsloth/Meta-Llama-3.1-405B-bnb-4bit\",    # We also uploaded 4bit for 405b!\n",
    "    \"unsloth/Mistral-Nemo-Base-2407-bnb-4bit\", # New Mistral 12b 2x faster!\n",
    "    \"unsloth/Mistral-Nemo-Instruct-2407-bnb-4bit\",\n",
    "    \"unsloth/mistral-7b-v0.3-bnb-4bit\",        # Mistral v3 2x faster!\n",
    "    \"unsloth/mistral-7b-instruct-v0.3-bnb-4bit\",\n",
    "    \"unsloth/Phi-3.5-mini-instruct\",           # Phi-3.5 2x faster!\n",
    "    \"unsloth/Phi-3-medium-4k-instruct\",\n",
    "    \"unsloth/gemma-2-9b-bnb-4bit\",\n",
    "    \"unsloth/gemma-2-27b-bnb-4bit\",            # Gemma 2x faster!\n",
    "] # More models at https://huggingface.co/unsloth\n",
    "\n",
    "model, tokenizer = FastLanguageModel.from_pretrained(\n",
    "    model_name = \"/data/jaesung/llm_for_diabetes/src/model/outputs/checkpoint-3214\",\n",
    "    max_seq_length = max_seq_length,\n",
    "    dtype = dtype,\n",
    "    load_in_4bit = load_in_4bit,\n",
    "    # token = \"hf_...\", # use one if using gated models like meta-llama/Llama-2-7b-hf\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<|begin_of_text|>Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
      "\n",
      "### Instruction:\n",
      "Recommend a daily diet that includes a specific ingredient.\n",
      "\n",
      "### Input:\n",
      "Create a diet that includes baby bok choy(roots trimmed and roughly chopped).\n",
      "\n",
      "### Response:\n",
      "{\"Breakfast\": \"Watermelon Quinoa Salad\", \"Lunch\": \"Grilled Chicken with Plums and Zucchini Skewers\", \"Dinner\": \"Turkey Meatball \\u201cWonton\\u201d Soup with Bok Choy & Carrots\"}<|end_of_text|>\n"
     ]
    }
   ],
   "source": [
    "\n",
    "\n",
    "FastLanguageModel.for_inference(model) # Enable native 2x faster inference\n",
    "\n",
    "# alpaca_prompt = You MUST copy from above!\n",
    "alpaca_prompt = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
    "\n",
    "### Instruction:\n",
    "{}\n",
    "\n",
    "### Input:\n",
    "{}\n",
    "\n",
    "### Response:\n",
    "{}\"\"\"\n",
    "\n",
    "\n",
    "inputs = tokenizer(\n",
    "[\n",
    "    alpaca_prompt.format(\n",
    "        \"Recommend a daily diet that includes a specific ingredient.\",\n",
    "\n",
    "        \"Create a diet that includes baby bok choy(roots trimmed and roughly chopped).\",\n",
    "\n",
    "        \"\", # output - leave this blank for generation!\n",
    "    )\n",
    "], return_tensors = \"pt\").to(\"cuda\")\n",
    "\n",
    "from transformers import TextStreamer\n",
    "text_streamer = TextStreamer(tokenizer)\n",
    "_ = model.generate(**inputs, streamer = text_streamer, max_new_tokens = 2048)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Task: alternative_diet, Sampled: 50\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'alternative_diet', 'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.', 'input': 'Cheese, cream', 'output': \"Herbed Soft Scrambled Eggs on Toast is recommended. The reason is 'Herbed Soft Scrambled Eggs on Toast' complements 'Cheese, cream' by providing a good source of protein, healthy fats, and essential vitamins and minerals. However, caution should be taken with the amount of added fats and sodium in the dish, especially if consumed frequently.\", '__index_level_0__': 36153}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'alternative_diet', 'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.', 'input': 'Turkey, ground', 'output': \"Almost Smooth Salsa is recommended. The reason is 'Almost Smooth Salsa' complements 'Turkey, ground' as it provides a low-calorie, low-fat option with added potassium and phosphorus. However, caution should be taken with the sodium content in the salsa, especially for individuals monitoring their sodium intake.\", '__index_level_0__': 36229}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'alternative_diet', 'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.', 'input': 'Ginger root, pickled', 'output': \"Orange Cream Italian Soda is recommended. The reason is 'Orange Cream Italian Soda' complements 'Ginger root, pickled' as it provides a low-calorie, low-sugar option with added potassium and phosphorus. However, caution should be taken as it may contain artificial sweeteners and flavorings which may not be suitable for everyone.\", '__index_level_0__': 36295}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'alternative_diet', 'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.', 'input': 'Salmon, baked or broiled, made with oil', 'output': \"Almost Smooth Salsa is recommended. The reason is 'Almost Smooth Salsa' can complement 'Salmon, baked or broiled, made with oil' as it is low in fat and calories, providing a fresh and flavorful addition to the meal. However, individuals should be cautious of the sodium content in the salsa, especially if they are monitoring their intake for health reasons.\", '__index_level_0__': 36551}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'alternative_diet', 'instruction': 'Based on the previous meal, suggest the next meal to maintain a balanced diet.', 'input': 'Cheese, NFS', 'output': 'Bountiful Harvest Vegetable Salad is recommended. The reason is Bountiful Harvest Vegetable Salad complements Cheese, NFS by providing a variety of nutrients such as fiber, potassium, and protein that are lacking in the consumed food. However, individuals should be cautious of the potential high fat content from the walnuts and dressing in the salad.', '__index_level_0__': 37048}\n",
      "Task: daily_diets, Sampled: 50\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'daily_diets', 'instruction': 'Recommend a daily diet based on the given nutritional goals.', 'input': 'Ensure the daily carbohydrate intake does not exceed 59.0g, protein intake is at least 48.0g, and fat intake does not exceed 12.0g.', 'output': '{\"Breakfast\": \"Whole Wheat Breakfast Pizzas\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Raspberry Swirl Frozen Yogurt Bark\"}', '__index_level_0__': 34068}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'daily_diets', 'instruction': 'Recommend a daily diet that includes a specific ingredient.', 'input': 'Create a diet that includes black pepper(for the roasted veggies).', 'output': '{\"Breakfast\": \"Asian Chicken Salad\", \"Lunch\": \"Curried Chickpea Stew with Roasted Vegetables\", \"Dinner\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\"}', '__index_level_0__': 35055}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'daily_diets', 'instruction': 'Recommend a daily diet based on the given nutritional goals.', 'input': 'Ensure the daily carbohydrate intake does not exceed 70.0g, protein intake is at least 42.0g, and fat intake does not exceed 25.0g.', 'output': '{\"Breakfast\": \"Hummus Deviled Eggs\", \"Lunch\": \"Beef & Broccoli Stir Fry\", \"Dinner\": \"Sweet Potato Shepherd\\\\u2019s Pie\"}', '__index_level_0__': 34363}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'daily_diets', 'instruction': 'Recommend a daily diet based on the given nutritional goals.', 'input': 'Ensure the daily carbohydrate intake does not exceed 48.0g, protein intake is at least 46.0g, and fat intake does not exceed 11.0g.', 'output': '{\"Breakfast\": \"Guilt-Free Breakfast Sausage Patties\", \"Lunch\": \"Turkey Meatball \\\\u201cWonton\\\\u201d Soup with Bok Choy & Carrots\", \"Dinner\": \"Roasted Sweet Potatoes with Lemon-Dill Yogurt Sauce\"}', '__index_level_0__': 33823}\n",
      "{'dataset': 'diabetes_food_hub', 'split_data': 'test', 'task': 'daily_diets', 'instruction': 'Recommend a daily diet that includes a specific ingredient.', 'input': 'Create a diet that includes SplendaÂ® Multi-Use Syrup(divided).', 'output': '{\"Breakfast\": \"Raspberry Swirl Frozen Yogurt Bark\", \"Lunch\": \"Turkey Sausage and Egg Casserole\", \"Dinner\": \"Tofu and Vegetable Skewers\"}', '__index_level_0__': 34870}\n",
      "Task: qa_objective_1, Sampled: 50\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 51-year-old woman schedules an appointment with her physician with complaints of upper abdominal pain, nausea, and early satiety for the last 6 months. She has type 1 diabetes for the past 10 years and is on subcutaneous insulin with metformin. She complains of occasional heartburn and lost 4.5 kg (10 lb) in the past 6 months without any changes in her diet. The medical history is significant for long QT syndrome. The vital signs include: pulse 74/min, respirations 18/min, temperature 37.7Â°C (99.9Â°F), and blood pressure 140/84 mm Hg. Abdominal examination is negative for organomegaly or a palpable mass, but there is a presence of succussion splash. She has slightly decreased vision in both her eyes and fundoscopy reveals diabetic changes in the retina. Esophagogastroduodenoscopy is performed, which is negative for obstruction, but a small ulcer is noted near the cardiac end of the stomach with some food particles. Which of the following drugs would be inappropriate in the management of this patientâ€™s condition? Please select one of the following: A) Bethanechol, B) Cisapride, C) Erythromycin, D) Domperidone.', 'output': 'B) Cisapride', '__index_level_0__': 31854}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 4-week-old Caucasian baby presents for a routine checkup. The patient was born to a 28-year-old G1P1 woman at 38 weeks estimated gestational age by cesarean section secondary to breech presentation. The pregnancy was complicated by gestational diabetes, which the mother controlled with diet and exercise. Prenatal ultrasounds showed normal fetal anatomy. Both parents are nonsmokers. The vital signs include: temperature 37.0Â°C (98.6Â°F), blood pressure 85/45 mm Hg, pulse 140/min, respiratory rate 42/min, and oxygen saturation 99% on room air. Height, weight, and head circumference are within the 90th percentile. Positive Moro and Babinski reflexes are present. The cardiopulmonary examination is normal. While in the supine position, the left leg is visibly shortened relative to the right. When the left hip is abducted with pressure applied to the greater trochanter of the femur, there is a non-tender clunking sound elicited. There is asymmetry of the labial skin folds. A blue macule is noted over the sacral region. Which of the following is the most appropriate next step in the management of this patient? Please select one of the following: A) Observation with follow-up in 6 months, B) Ultrasound of the hips, C) Ultrasound of the lumbosacral spine, D) X-ray of the hips.', 'output': 'B) Ultrasound of the hips', '__index_level_0__': 31762}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 54-year-old man was brought to the emergency room due to acute onset of slurred speech while at work, after which he lost consciousness. The patientâ€™s wife says this occurred approximately 30 minutes ago. Past medical history is significant for poorly controlled hypertension and type 2 diabetes mellitus. His blood pressure is 90/50 mm Hg, respiratory rate is 12/min, and heart rate is 48/min. The patient passes away shortly after arriving at the hospital. At autopsy, bilateral wedge-shaped strips of necrosis are seen in this patientâ€™s brain just below the medial temporal lobes. Which of the following is the most likely location of these necrotic cells? Please select one of the following: A) Hippocampus, B) Caudate nucleus, C) Cortex or cerebral hemisphere, D) Substantia nigra.', 'output': 'A) Hippocampus', '__index_level_0__': 31765}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 24-year-old G1P0 presents to her obstetrician at 26 weeksâ€™ gestation complaining of worsening headaches and blurry vision. Her past medical history is notable for hypertension and diabetes mellitus. Her temperature is 98.6Â°F (37Â°C), blood pressure is 160/95 mmHg, pulse is 100/min, and respirations are 18/min. On physical exam, she is tender to palpation in her abdomen and has mild edema in her extremities. A urine dipstick demonstrates 3+ protein. The patient is immediately started on IV magnesium sulfate, diazepam, and a medication that affects both a- and ÃŸ-adrenergic receptors. Which of the following medications is most consistent with this mechanism of action? Please select one of the following: A) Labetalol, B) Metoprolol, C) Esmolol, D) Pindolol.', 'output': 'A) Labetalol', '__index_level_0__': 31833}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 45-year-old man comes to the physician for a routine health maintenance examination. He feels well. He has type 2 diabetes mellitus. There is no family history of serious illness. He works as an engineer at a local company. He does not smoke. He drinks one glass of red wine every other day. He does not use illicit drugs. His only medication is metformin. He is 180 cm (5 ft 11 in) tall and weighs 100 kg (220 lb); BMI is 31 kg/m2. His vital signs are within normal limits. Examination shows a soft, nontender abdomen. The liver is palpated 2 to 3 cm below the right costal margin. Laboratory studies show an aspartate aminotransferase concentration of 100 U/L and an alanine aminotransferase concentration of 130 U/L. Liver biopsy shows hepatocyte ballooning degeneration, as well as inflammatory infiltrates with scattered lymphocytes, neutrophils, and Kupffer cells. Which of the following is the most likely diagnosis? Please select one of the following: A) Primary biliary cirrhosis, B) Viral hepatitis, C) Nonalcoholic steatohepatitis, D) Autoimmune hepatitis.', 'output': 'C) Nonalcoholic steatohepatitis', '__index_level_0__': 31831}\n",
      "Task: summarization, Sampled: 42\n",
      "{'dataset': 'pubmed', 'split_data': 'test', 'task': 'summarization', 'instruction': 'Write a summary of the article that captures the main ideas and significant details.', 'input': \"obesity abets several life style diseases such as diabetes type ii , atherosclerosis , or impaired wound healing . these adverse effects can be avoided or , if already present , reduced by physical activity . \\n exercise training and increased catecholamine levels affect adipocyte metabolism , on one hand by influencing insulin secretion   and on the other hand by additionally channelling the adipocyte metabolism towards lipolysis . \\n adenylyl cyclase transforms atp into cyclic amp ( camp ) , which in turn increases the activity level of camp - dependent protein kinase a ( pka ) [ 3 , 4 ] . \\n activation of the insulin receptor results in decreased lipolysis , increased lipogenesis and uptake of fatty acids . \\n lipolysis is decreased by insulin - receptor - induced phosphodiesterase-3b ( pde-3b ) and 14 - 3 - 3beta - dependent reduction of pka activity [ 3 , 5 ] . \\n furthermore , the insulin receptor activates several lipogenic enzymes by tyrosine phosphorylation and promotes glut-4 recruitment to the cell membrane . \\n protein tyrosine phosphatase interacting protein 51 ( ptpip51 ) is expressed in different organs with a multitude of functions [ 7 , 8 ] . as previously shown for mouse adipose tissue , ptpip51 acts as an effector in insulin signalling . \\n ptpip51 expression was correlated to the insulin resistance of the animals , according to the expression of its interaction partner protein tyrosine phosphatase 1b ( ptp1b ) . \\n in addition to that , ptpip51 is connected to the lipolytic mapk pathway by its interaction with raf-1 mediated by 14 - 3 - 3beta . \\n 14 - 3 - 3beta also interacts with phosphodiesterase 3b , resulting in reduced intracellular camp levels and decreased pka activity . as 14 - 3 - 3beta and \\n ptp1b are important for adipocyte metabolism control , the role of its interaction partner ptpip51 needs to be disclosed . \\n the interaction of ptpip51 with the insulin receptor and pka was investigated in adipose tissue from animals kept under different defined experimental conditions to search for a potential role of ptpip51 in adipocyte metabolism . \\n the experiments were performed with male c57bl/6 mice ( n = 40 ) and approved by the local animal care and use committee ( gi 20/24 nr . \\n the animals were kept under standard conditions ( 12  h light / dark cycle ) with no access to running wheels . \\n the experiments were run for 14 weeks , with a four - week period of fat feeding followed by a ten - week training period . \\n control group ( sd ) : the animals were fed a standard diet ( altromin standard diet no . 1324 , altromin , lage , germany ) . \\n endurance training control group ( sdt ) : the animals were fed a standard diet ( altromin standard diet no . 1324 , altromin , lage , germany ) and trained for a period of ten weeks . \\n the training was performed on a motorized treadmill for 35  min / day at 12  m / min , at 12% grade , 5 times per week , for ten weeks . \\n running speed was 0.27  m / s  0.05  m / s corresponding to 80% of maximal oxygen consumption . \\n high - fat - diet group ( hfd ) : the animals were fed a high - fat diet containing 45% fat for 14 weeks of the experimental period . high - fat - diet , training group ( hfdt ) : the animals were fed a high - fat - diet during the complete experimental time period . the endurance training period started four weeks after the beginning of high - fat - diet feeding and was similar to the training described above . \\n after 14 weeks , the animals were sacrificed in the morning between 10 and 12 o'clock and the abdominal adipose tissue was frozen in liquid nitrogen precooled isopentan , and transferred to 80c till further analysis . \\n a glucose tolerance test was performed to determine the insulin sensitivity of the mice [ 911 ] . for testing the glucose tolerance of the animals , they were injected intraperitoneally with 2 \\n g of 20% d - glucose dissolved in sterile 0.9% nacl solution per kg body weight . \\n the test was performed in the morning ; last feeding of the animals took place the previous day . \\n an antibody against a defined peptide sequence at the c - terminus of ptpip51 ( sequence : iqkdleelevilrd , exon 13 ) was produced ( biolux , stuttgart , germany ) . \\n identity and purity of the synthesized peptide were approved by esi - ms and uv - analysis . \\n the primary ptpip51 antibody to the c - terminus was used in 1  :  800 dilutions and visualized by alexa 555 ( molecular probes , darmstadt , germany , cat . \\n primary monoclonal mouse antibodies were used for double staining experiments with pka ( ab58187 , abcam plc , 330 cambridge science park , cambridge , uk ) and the beta - subunit of the ir ( clone ct-3 , millipore , 28820 single oak drive , temecula , ca , usa ) . to avoid unspecific binding of the primary mouse antibodies \\n , samples were preincubated with biotin - coupled anti - mouse - antibodies for one hour . \\n the reaction of the primary monoclonal mouse antibody was visualized using alexa fluor 488 secondary antibodies ( molecular probes , darmstadt , germany , cat . \\n confocal images of cells were obtained with a leica confocal laser scanning microscope ( clsm , 5 tcs sp2 , leica , bensheim , germany ) . \\n confocal images of alexa fluor 555 fluorescence were acquired using 6 plan - apochromat    40/1.4 oil objective , 548  nm excitation wavelengths ( helium - neon laser ) , and a 560585  nm band - pass filter . \\n the pinhole diameter was set to yield optical sections of 1 airy unit . for the detection of alexa fluor 488 \\n , we used a plan - apochromat  40/1.4 oil objective , the 488  nm excitation wavelength of an argon laser , and a 505530  nm band - pass filter . \\n t3605 ) ( nuclear staining ) were acquired using plan - apochromat  40/1.4 oil objective , 633  nm excitation wavelengths ( helium - neon laser ) , and the 650670  nm bandpass filter . \\n the pinhole diameter was set to yield optical sections of 1 airy unit . acquired dic and confocal images \\n acquired images were subsequently processed by imagej ( v1.43  m ; rasband , w.s . , imagej , us national institutes of health , bethesda , md , usa , http://imagej.nih.gov/ij/ , 19972011 ) using an iterative deconvolution plug - in by bob dougherty ( http://www.optinav.com/imagej.html , iterative deconvolution ) . options were set for all confocal acquired images as follows : 8 numbers of iteration and 2.0  pixels of lp filter diameter . \\n point spread function was calculated for each channel separately by the imagej plug - in created by bob dougherty ( http://www.optinav.com/imagej.html , diffraction limit psf ) . \\n intensity correlation analysis ( ica ) was carried out using imagej ( v1.43  m ; rasband , w.s . , \\n imagej , us national institutes of health , bethesda , md , usa , http://imagej.nih.gov/ij/ , 19972011 ) and an appropriate plug - in for ica included in the plug - in package of the wright cell imaging facility   ( http://www.uhnres.utoronto.ca/facilities/wcif/fdownload.html ) . \\n interaction of ptpip51 with either pka or beta - subunit of the ir was detected by the proximity ligation assay kit duolink ( olink |bioscience , uppsala , sweden , pla probe anti - rabbit minus for the detection of the rabbit ptpip51 antibody , cat . \\n 90602 ; pla probe anti - mouse plus for the detection of the mouse anti pka or ir antibody , cat . \\n the dpla was performed according to the manufacturer 's protocol ; negative controls were included [ 9 , 14 , 15 ] . for the principle of the dpla , see figure 1 . \\n the axioplan 2 fluorescence microscope equipped with plan - apochromat objectives ( carl zeiss jena , germany ) was used for photo documentation . for visualization of the dpla , \\n an excitation filter with a spectrum of 530560  nm and an emission filter with a spectrum of 572647  nm were used . \\n the duolink image tool ( olink biosciences , uppsala , sweden ) was used for quantification of the detected dpla signals . \\n we accomplished a database research using the gps 2.1 database   to identify kinases within adipocyte metabolism that possess the ability to phosphorylate ptpip51 . \\n the observed data were analysed by nonparametrical tests to determine the significance of the results . \\n the glucose tolerance was determined by a standard glucose tolerance test at the end of the experimental period . \\n sd and sdt animals displayed a slight increase of blood glucose levels 30 minutes after application of glucose which was almost normalized after 60 minutes . \\n in hfd animals , blood glucose levels strongly increased from the basal level of 100  mg / dl to 400  mg / dl 60 minutes after application . \\n blood glucose levels did not return to normal values within 120 minutes . in hfdt animals , \\n blood glucose levels increased to 270  mg / dl 30 minutes after application and almost returned to normal values after 120 minutes ( figure 2 ) . \\n the values of hfd , hfdt , and animals fed a standard diet ( sd and sdt ) are significantly different after 30 and 60 minutes . \\n after 120 minutes , the differences between standard diet and high fat diet animals remained significant , whereas there was no significant difference between standard diet and trained high - fat - diet animals . \\n mean body weight was measured at different time points throughout the test ( see table 2 ) . \\n statistical analysis showed that there was no significant difference between the four groups at 10 weeks of age . from the beginning of the training , \\n the difference between standard diet and high - fat - diet - fed groups was highly significant , but there was no significant difference between the sd and sdt and , respectively hfd and hfdt groups . \\n ptpip51 immunoreactivity was detected within the cytoplasm and at the plasma membrane ( figure 3 ) . \\n the ir revealed a similar expression pattern when compared to ptpip51 . in the cytoplasm , \\n co - localization is displayed in yellow to orange and non - co - localized parts are shown in blue . \\n the duolink proximity ligation assay ( dpla ) was performed to detect interactions between ptpip51 and the beta - subunit of the ir . \\n the interaction of ptpip51 and ir was verified as seen in figure 4 , where each dot indicates the interaction of both proteins . \\n this interaction of ptpip51 and the ir was found in the adipocytes of animals from all experimental groups . \\n the grade of interaction in adipose samples from sd animals corresponds to the level in hfdt animals . \\n the assumption of an interaction of ptpip51 and pka based on the database research was verified ( figure 4 ) . \\n the interaction levels of sd , hfd , and hfdt mice did not show significant differences . \\n to sum up the results , adipocytes from mice subjected to different diets and activity levels displayed a connection between ptpip51 and the insulin receptor , and ptpip51 and pka respectively . \\n the glucose - tolerance test revealed a glucose - intolerant status in hfd and hfdt animals , whereas the glucose tolerance of hfdt animals improved compared to hfd animals . \\n immunofluorescence data displayed colocalization of ptpip51 with ir and pka suggesting an interaction between ptpip51 and ir , and ptpip51 and pka respectively . \\n search results displayed ptpip51 to be phosphorylated at tyrosine 176 by the insulin receptor and at serine 46 by pka . \\n these two phosphorylation sites are possible regulatory sites for the interaction of ptpip51 with 14 - 3 - 3beta , thus being able to influence the mapk pathway by interaction with raf-1 . \\n phosphorylation of serine 46 in ptpip51 results in augmented interaction with raf-1 via 14 - 3 - 3 and thus in increased erk1/2 phosphorylation , promoting the mapk pathway [ 12 , 17 ] . \\n pka is known to induce lipolysis through the mapk pathway [ 18 , 19 ] . \\n the insulin receptor induces tyrosine phosphorylation of ptpip51 at tyrosine 176 , which leads to reduced interaction of ptpip51 with 14 - 3 - 3beta and raf-1 , thereby decreasing the mapk pathway activity . \\n analysis of the ptpip51 interaction profile of adipocytes displayed high interaction levels with the insulin receptor in hfd animals . \\n interaction levels were reduced by 30% in sd and hfdt and by 50% in sdt animals , compared to hfd animals . \\n high - fat feeding increases the lipogenic activity in adipose tissue [ 21 , 22 ] . \\n the reduced ptpip51-ir interaction in trained groups compared to the corresponding untrained groups suggests that ptpip51 is especially involved in the processes of insulin induced lipogenesis or in its antilipolytic action . \\n interaction levels between ptpip51 and pka did not show significant differences in sd , hfd , and hfdt animals . in sdt animals , \\n but , as pka also interacts with the hormone - sensitive lipase ( hsl ) , a change of the interaction partner of pka away from ptpip51 under these preconditions is assumable . \\n the activities of both pka and hsl are increased in endurance - trained animals [ 24 , 25 ] . \\n our experiments suggest that ptpip51 could mediate between lipogenesis and lipolysis by switching between the lipogenic insulin pathway and the lipolytic pka pathway . \\n further experiments need to be conducted in order to prove our hypothesis and to determine the magnitude in which ptpip51 engages in adipocyte metabolism .\", 'output': 'aims . \\n our previous experiments revealed an association of ptpip51 ( protein tyrosine phosphatase interacting protein 51 ) with the insulin signalling pathway through ptp1b and 14 - 3 - 3beta . \\n we aimed to clarify the role of ptpip51 in adipocyte metabolism . \\n methods . \\n four groups of ten c57bl/6 mice each were used . \\n two groups were fed a standard diet ; two groups were fed a high - fat diet . \\n two groups ( one high - fat diet and one standard diet ) were submitted to endurance training , while the remaining two groups served as untrained control groups . \\n after ten weeks , we measured glucose tolerance of the mice . \\n adipose tissue samples were analyzed by immunofluorescence and duolink proximity ligation assay to quantify interactions of ptpip51 with either insulin receptor ( ir ) or pka . \\n results . ptpip51 and the ir and ptpip51 and pka , respectively , were colocalized in all groups . \\n standard diet animals that were submitted to endurance training showed low ptpip51-ir and ptpip51-pka interactions . \\n the interaction levels of both the ir and pka differed between the feeding and training groups . \\n conclusion . \\n ptpip51 might serve as a linking protein in adipocyte metabolism by connecting the ir - triggered lipogenesis with the pka - dependent lipolysis . ptpip51 \\n interacts with both proteins , therefore being a potential gateway for the cooperation of both pathways .', '__index_level_0__': 32859}\n",
      "{'dataset': 'pubmed', 'split_data': 'test', 'task': 'summarization', 'instruction': 'Write a summary of the article that captures the main ideas and significant details.', 'input': 'in the previous issue of critical care , otto and colleagues   used in vitro studies to explore the theory that immunological activation induced by hyperglycemia is the result of hyperosmololaity . \\n there is , in fact , a growing body of literature on osmotic regulation of cell function with possible implications on clinical outcomes . at the forefront of this research \\n is the use of hypertonic solutions to attenuate inflammation and immunosuppression following traumatic injury or sepsis [ 3 - 5 ] . \\n it is widely known that administration of hypertonic solutions promotes a more balanced inflammatory response that may improve outcomes . \\n otto and colleagues   suggest that immunomodulation , by correction of hyperglycemia , is a contributing factor to the efficacy of intensive insulin therapy ( iit ) in critically ill patients , as proposed by van den berghe and colleagues . \\n their ex vivo studies suggested that hyperglycemia , via hyperosmolarity , potentiates the production of cytokines by peripheral blood mononuclear cells ( pbmcs ) in response to lipopolysaccharide ( lps ) stimulation . \\n furthermore , they examined the effect of hyperglycemia on phagocytosis and oxidative burst in human granulocytes and found the responses reduced with hyperglycemia . \\n they postulated that the efficacy of iit may be due , at least in part , to the correction of hyperosmolality induced by the lowering of blood glucose in response to insulin administration . \\n when assessing the effect of various solutions , there must be a clear distinction between the osmolality and tonicity . \\n osmolality and osmolarity refer to the property of a solution in the absence of reference to a membrane . \\n tonicity , on the other hand , is in reference to a membrane and is equal to the molecular concentrations of the solutes that exert an osmotic force across the membrane . \\n thus , a highly permeable solute , such as glucose , does not exert a high tonicity . \\n the majority of solutes that have been demonstrated to attenuate immunological response to injury or infection have been hypertonic , specifically , sodium chloride . \\n otto and colleagues tried to address the issue of osmolality and tonicity by contrasting responses to hyperglycemia to those of an equally hyperosmotic solution , mannitol . \\n mannitol is a hypertonic solution , whereas glucose is usually considered isotonic . in response to lps stimulation , hyperglycemia enhanced the production of interleukin ( il)-6 and il-1 ; however , mannitol produced no significant difference ( compared with control ) . \\n otto and colleagues further investigated the hypertonicity of hyperglycemia by supplementing the incubation media with insulin to facilitate cellular uptake of glucose , resulting in a reduction in tonicity . \\n the authors claimed that the inclusion of insulin partially reversed the production of cytokines ; however , the only significant decrease was for il-1 at the highest dose of insulin and glucose . \\n the inability of mannitol to induce an increased cytokine response and the absence of a consistent attenuation of the response with insulin suggest that factors other than hyperosmolality and hypertonicity are involved in the potentiation of cytokine responses by hyperglycemia . \\n otto and colleagues increased the glucose concentrations from 100 mg / dl to 250 , 500 , and 1,000 mg / dl . \\n theoretically , this would increase plasma osmolality by 8 , 22 , and 50 mosm / kg , respectively . \\n but as noted above , changes in cytokines were mostly observed at only the highest glucose level , representing a supra - physiological plasma glucose concentration and thus osmolality . \\n alterations in phagocytosis and oxidative burst in human granulocytes were determined at only the 500 mg / dl glucose level , an upper clinical limit . \\n similar supra - physiological increases in hyperosmolality have been used in the evaluation of other solutes . \\n thus , while these ex vivo findings are interesting , when the dose levels are considered clinical application may be limited . \\n the profound effect of hypertonic saline on immunological responses both in vitro and in vivo is extensively explored in the literature . \\n exposure to hypertonic saline reduces pbmc function in response to activation of the p38 mapk ( mitogen - activated protein kinase ) . \\n this reduction in function correlates with a decrease in inflammation and tissue damage in vivo . \\n in contrast , otto and colleagues demonstrated an increase in activity of pbmc function with exposure to hyperglycemia , suggesting an alternate function other than hyperosmolality . \\n in addition , otto and colleagues found hyperglycemia to reduce phagocytosis and oxidative burst in human granulocytes . \\n there are various interpretations as to the advantages or disadvantages of attenuation of these responses . in the acute phase , this reduction may , in fact , attenuate tissue damage . \\n otto and colleagues reported enhancement of immunological responses to lps in the presence of hyperglycemia . \\n this response does not appear to be mediated by hyperosmolality as postulated by the authors but by another mechanism . \\n their study emphasizes the absence of information able to explain the underlying mechanisms responsible for the purported improvements in clinical outcomes of critically ill patients following correction of hyperglycemia by iit . \\n iit : intensive insulin therapy ; il : interleukin ; lps : lipopolysaccharide ; pbmc : peripheral blood mononuclear cell .', 'output': 'in the previous issue of critical care , otto and colleagues used in vitro studies to explore the theory that immunomodulation , by correction of hyperglycemia , may be a contributing factor to the reported efficacy of intensive insulin therapy ( iit ) in critically ill patients . \\n they suggested that hyperglycemia via hyperosmolarity at supra - physiological levels potentiates the production of cytokines by peripheral blood mononuclear cells in response to lipopolysaccharide ( lps ) stimulation and that it also reduces the responses of phagocytosis and oxidative burst in human granulocytes . \\n the efficacy of iit , they concluded , may be partially due to the correction of hyperosmolality \\n . other studies , however , have suggested that immunological responses to lps in the presence of hyperglycemia are mediated by a mechanism other than hyperosmolality .', '__index_level_0__': 32646}\n",
      "{'dataset': 'pubmed', 'split_data': 'test', 'task': 'summarization', 'instruction': 'Write a summary of the article that captures the main ideas and significant details.', 'input': 'the hormone betatrophin , primarily produced in the liver , was recently described as a key stimulator of beta - cell mass expansion in response to obesity and insulin - resistant states in mice . \\n in fact , a 17-fold increase in beta - cell proliferation was observed when the hormone was overexpressed . \\n presently , the development of drugs with betatrophin as the active component is considered for the treatment of both type 1 and type 2 diabetes . in humans , an increased beta - cell mass by approximately 50% \\n although minimal human beta - cell replication has been observed in such autopsy studies and in a mouse model of induced insulin resistance , human beta cells may proliferate in response to an obesogenic environment in mice [ 4 , 5 ] . \\n in contrast , in obese humans with type 2 diabetes a 4060% deficit in beta - cell mass when compared to bmi - matched healthy controls has been reported [ 6 , 7 ] . \\n this may merely reflect beta - cell loss by apoptosis in manifest diabetes and could also mirror a primary defect in the beta cells to adapt and expand in response to obesity and insulin resistance . the present study aimed to investigate circulating betatrophin concentrations in type 2 diabetes patients and in bmi - matched controls without diagnosed diabetes , testing the hypothesis of a betatrophin deficiency in individuals with diabetes . \\n the study was approved by the regional ethical board of uppsala county and conducted in accordance with the declaration of helsinki as revised in 2000 . \\n all study participants were given oral and written information and signed a consent form prior to inclusion in the study . \\n patients with type 2 diabetes ( n = 27 ) were identified from the uppsala - based diabetes registry andiu ( http://www.andiu.se ) or the swedish national diabetes registry ( http://www.ndr.nu ) . \\n the inclusion criteria were based on who diagnosis criteria . only patients with glucose - lowering treatment were included . \\n most of the patients had metformin as monotherapy ( n = 19 ) or in combination with another oral antidiabetic drug ( oad ) ( n = 3 ) , and one patient ( n = 1 ) was treated with metformin in combination with exogenous insulin . \\n two patients ( n = 2 ) had another oad as monotherapy and two patients ( n = 2 ) exogenous insulin . \\n age- , gender- , and bmi - matched nondiabetic controls ( n = 18 ) were recruited through advertising at a local health care center . \\n inclusion criteria for controls were apart from described parameters ; no history of diabetes , and no first - degree relative with diabetes . \\n all study participants were characterized with regard to regarding weight , height , waist- and hip circumference , blood pressure and family history of diabetes , for descriptive data see table 1 . \\n betatrophin levels were analysed with an elisa ( wuhan eiaab science , wuhan , china ; catalogue number . \\n all samples were analysed as duplicates and samples with coefficient of variation ( cv ) values > 15% were excluded . \\n we have in a previous publication confirmed the reliability of obtained elisa values with western immunoblotting with a primary antibody ( phoenix pharmaceuticals , phoenix , usa ; wbk-051 - 55 ) . \\n beta - cell function at steady state ( % b ) , insulin sensitivity ( % s ) , and insulin resistance ( ir ) was estimated with the updated homeostasis model assessment ( homa2 ) , and calculated based on fasting plasma glucose and fasting plasma c - peptide with the homa2 calculator v2.2 diabetes trials unit , university of oxford . \\n an unpaired two - tailed t test was used to compare differences between the groups . \\n circulating levels of betatrophin were approximately 40% higher in the type 2 diabetes patients when compared to their controls ( 893  80 versus 639  66  pg / ml ; p = 0.03 ) , whereas there was no difference in gender distribution , age , bmi , waist - hip circumference , or waist - to - hip ratio between the two groups ( table 1 ) . \\n as expected , fasting plasma glucose and hba1c were higher in the type 2 diabetes patients ( glucose 8.5  0.4 versus 6.2  0.2  mmol / l for controls , p < 0.0001 ; hba1c 6.8  0.1% ( 50.6  1.6  mmol / mol ) versus 5.8  0.1% ( 40.1  0.8  mmol / mol ) for controls , p < 0.0001 ) , but control individuals fulfilled the ada criteria for impaired fasting plasma glucose . \\n the patients with type 2 diabetes had a lower homa2%b ( reflecting beta - cell function at steady state ) index when compared to controls ( 77.9  8.3 versus 108.8  6.0 , p = 0.008 ) , whereas there was no difference in homa2%s ( reflecting insulin sensitivity ) or homa2 ir ( reflecting insulin resistance ) . \\n the plasma levels of cholesterol , hdl cholesterol , and ldl cholesterol were higher in the control group . \\n however , the number of study participants using lipid - lowering drugs ( statins ) was lower in the control group ( 22% versus 48% ) , although the difference was not statistically significant . for plasma triacylglycerol levels \\n there was no difference between the two groups . in controls , we observed a positive correlation between betatrophin concentrations and age ( cc = 0.572 , p = 0.01 ) ( figure 1(a ) ) , whereas in the type 2 diabetes group there was no such correlation ( table 2 ) . \\n however , in the type 2 diabetes patients we instead observed a positive correlation between plasma betatrophin levels and hba1c ( cc 0.482 , p = 0.01 ) ( figure 1(b ) ) . there were no correlations between plasma betatrophin and other markers of metabolic control , for example , fasting plasma glucose concentrations , c - peptide concentrations , or any homa index , in either the controls or type 2 diabetes patients . \\n similarly , there were no correlations between plasma betatrophin levels and blood lipid levels in either the controls or type 2 diabetes patients . \\n when computing correlations for all study participants , regardless of whether they were controls or patients with type 2 diabetes , we observed a positive correlation between plasma betatrophin concentrations and hba1c ( figure 1(c ) ) , similarly as in the type 2 diabetes group , but not with age as was observed in the control group . \\n there was a tendency towards a positive correlation with plasma creatinine ( cc = 0.267 , p = 0.06 ) but not with the glomerular filtration rate ( gfr ) calculated with mdrd based on creatinine levels ( cc = 0.208 , p = 0.170 ) . \\n there was also a tendency towards a negative correlation between plasma betatrophin and plasma cholesterol ( cc = 0.286 , p = 0.06 ) , when computing correlations for all study participants . \\n we therefore subanalysed the study participants with regard to whether they were treated with lipid - lowering drugs ( table 3 ) . among the controls , \\n only four individuals were treated with lipid - lowering drugs , and when comparing them to controls without treatment ( n = 14 ) , we observed no statistical difference with regard to plasma betatrophin , cholesterol , hdl cholesterol , ldl cholesterol , triacylglycerols , or bmi . among the patients with type 2 diabetes , \\n there were 14 patients that were treated with lipid - lowering drugs and 13 that were not . \\n plasma ldl cholesterol was lower in the subjects treated with lipid - lowering drugs , whereas there was no difference for plasma betatrophin , cholesterol , hdl cholesterol , triacylglycerols , hba1c , fasting plasma glucose , or bmi . \\n the present work shows that plasma betatrophin concentrations in patients with type 2 diabetes are not subnormal , instead higher concentrations than in nondiabetic individuals were recorded . therefore , although resistance to betatrophin effects in type 2 diabetes patients can not be excluded , there is at least no obvious betatrophin deficiency to substitute in these individuals . \\n we have previously reported on betatrophin concentrations in young adult healthy controls and patients with type 1 diabetes . \\n the presently recorded betatrophin concentrations in controls were approximately doubled when compared to those in the previous study . \\n however , at least in mice , betatrophin expression has been shown to be primarily regulated by insulin resistance in liver . the controls in the previous study had a mean bmi of 23 , whereas it was 29  kg / m in the present study . moreover , the present controls had a mean waist circumference exceeding 100  cm and mean homa2 ir values well exceeding the 75 percentile ( homa2 ir 1.133 ) of a normal scandinavian population . also when insulin sensitivity was calculated as homa2%s values , these values were in the present controls only half of those in a normal caucasian population . \\n thus , the assigned control group in the present study was clearly insulin resistant similar to the patients with type 2 diabetes but had not developed similar decrease in beta - cell function ( as assessed by homa2%b ) , despite fulfilling the ada criteria for impaired fasting glucose . \\n although no strict correlations were observed between homa2 indices and plasma betatrophin levels , the higher betatrophin concentrations observed in the present study suggest that betatrophin expression also in humans may be induced by insulin resistance . \\n a limitation with the present study was that insulin resistance was not measured by a glucose - clamp technique but instead estimated by homa2 ir indices . \\n nevertheless , such indices are generally considered to preferentially reflect insulin resistance in liver rather than overall insulin resistance . in this study , \\n most of the patients were treated with metformin , which is considered as first line of treatment according to ada and easd position statement . \\n therefore , very few patients with diagnosed type 2 diabetes were identified , who were treated with other antidiabetic drugs or only had diet and exercise as treatment . theoretically , treatment with metformin \\n could decrease plasma betatrophin levels , since it reduces insulin resistance which is described as the main stimulus for betatrophin secretion . in four identified patients without metformin \\n there was in fact a tendency towards increased betatrophin levels when compared to those treated with metformin ( 1241  167 ( n = 4 ) versus 832  85 ( n = 23 ) pg / ml , p = 0.0694 ) . \\n however , since the number of patients without metformin treatment is limited this would have to be further investigated . \\n our correlation analysis also identified that the plasma betatrophin concentrations in nondiabetic humans increase with age . \\n moreover , when including the type 2 diabetes patients with variable metabolic control , plasma betatrophin concentrations were observed to increase with hba1c . \\n noteworthy , there also tended to be a positive correlation between plasma betatrophin concentrations and plasma creatinine , which would suggest that betatrophin normally is excreted in the urine , although there was no correlation between calculated gfr and betatrophin . increased circulating concentrations of betatrophin \\n may both reflect increased secretion and reduced clearance of the hormone , but there were no differences in plasma creatinine or calculated gfr between the type 2 diabetes patients and their controls . \\n betatrophin belongs to the family of angiopoietin - like proteins and has besides betatrophin been given many different names : lipasin , hepatocellular carcinoma - associated protein - td26 , rifl , and angiopoietin - like protein 8 [ 1316 ] . \\n overexpression of betatrophin in mice leads to an increase in serum triacylglycerol , and human genome - wide association studies have also shown that variations in the gene are linked with blood lipid levels . in the present study \\n , there tended to be a negative correlation between betatrophin concentrations and total plasma cholesterol levels . \\n however , the association between betatrophin and lipid values was difficult to interpret , since several of the study patients , especially among the patients with diabetes , were treated with lipid - lowering drugs ( statins ) . \\n indeed , total plasma cholesterol , ldl , and hdl were all decreased in the type 2 diabetes patients when compared to the controls . since this study only included 45 patients , any subanalysis of betatrophin concentrations in patients with or without lipid treatment was difficult to perform with enough statistical power . \\n nevertheless , there seemed to be no clear difference in plasma betatrophin concentrations between statin and nonstatin treated individuals . during the preparation of this paper , fenzl et al .   reported no difference in plasma betatrophin levels between type 2 diabetes patients and nondiabetic controls in a retrospective study of stored plasma samples . \\n this finding contradicts with the present results and previous findings on betatrophin gene expression in insulin - resistant mice . \\n the reasons for the different results obtained are presently obscure , and any potential influence of long - term or variable storage time or occurrence of any repeated freeze - thaw cycles of samples was not reported . nevertheless , although their results showed no difference between nondiabetic and type 2 diabetic patients , there was , similar to in our study , at least no deficiency of betatrophin in the diabetic state . \\n we conclude that plasma betatrophin concentrations are increased in type 2 diabetes patients when compared to age- , gender- , and bmi - matched controls with similar degree of insulin resistance . \\n therefore , there is no obvious betatrophin deficiency to substitute in these diabetic individuals , and similar to our previous study in type 1 diabetes patients the increased plasma betatrophin concentrations seem insufficient to compensate for the development of disease by triggering a beta - cell mass expansion . \\n future studies are clearly needed to delineate the exact role , if any , for betatrophin in regulating human beta - cell mass .', 'output': 'betatrophin has recently been described as a key hormone to stimulate beta - cell mass expansion in response to insulin resistance and obesity in mice . \\n the finding has generated an interest in the development of antidiabetic drugs with betatrophin as the active component . \\n however , the circulating levels of betatrophin in patients with type 2 diabetes are not well known . \\n betatrophin concentrations in plasma of 27 type 2 diabetes patients and 18 gender- , age- , and bmi - matched controls were measured . \\n study participants were characterized with regard to bmi , waist and hip circumference , blood pressure , and fasting plasma blood lipids , creatinine , glucose , hba1c , and c - peptide . \\n homa2 indices were calculated . \\n betatrophin was 40% higher in patients with type 2 diabetes ( 893  80 versus 639  66  pg / ml ) . \\n betatrophin positively correlated with age in the controls and with hba1c in the type 2 diabetes patients . \\n all study participants were insulin resistant with mean homa2b ir in both groups exceeding 2 and homa2%s < 50% . \\n control individuals had impaired fasting glucose concentrations . in this report on betatrophin concentrations in type 2 \\n diabetes and insulin resistance , elevated betatrophin levels were measured in the patients with type 2 diabetes . \\n future studies are clearly needed to delineate the exact role , if any , of betatrophin in regulating human beta - cell mass .', '__index_level_0__': 32948}\n",
      "{'dataset': 'pubmed', 'split_data': 'test', 'task': 'summarization', 'instruction': 'Write a summary of the article that captures the main ideas and significant details.', 'input': \"insulin is a major therapeutic tool for insulin - deficient patients with type 1 diabetes mellitus , and also for patients with type 2 diabetes mellitus ( t2d ) , with both insulin resistance and a relative insulin deficiency . \\n its effects on glucose metabolism are well known , but insulin also influences lipid and protein metabolism with anabolic and anticatabolic effects . \\n these have been less studied despite body weight ( bw ) gain being an important consequence of insulin therapy , identified in both the dcct   and ukpds   studies . \\n bw gain is probably a benefit in purely insulin - deficient patients in whom lack of insulin is responsible for lean tissue loss , but in t2d the worsening of existing obesity seems undesirable . \\n analysis of body composition ( bc ) changes can help determine whether insulin - induced bw gain can be considered as beneficial or not , by distinguishing the accumulation of fat ( fm ) from that of fat - free mass ( ffm ) . \\n ffm is an important nutritional parameter , linked with immune competence , functional status , and survival . \\n previous studies on the influence of insulin therapy on bc of patients with diabetes mellitus have been limited because the methods for analyzing bc ( tritiated water , underwater weighing or four - compartment model ) are difficult to use in clinical practice . \\n air displacement plethysmography is a new , safe , quick , and valid technique , providing accurate measurements of body density   and discriminating moderate changes in fm and ffm . \\n although some uncertainties due to the hydration of ffm may influence any two - compartment model - based analysis , the simultaneous measurement of muscle strength ( ms ) by dynamometry can be used to confirm the results of ffm : a correlation between ffm and ms has been previously demonstrated [ 911 ]   the aim of our study was to assess the effects of insulin therapy on body weight and composition , and on muscular strength , in t2d with failure to oral hypoglycaemic agents . \\n 40 type 2 diabetic patients ( 18 men and 22 women ) who presented secondary failure to oral antidiabetic agents with hba1c > 7% after a duration of 13.5  8.7 years of diabetes mellitus were recruited during their stay in our department . \\n exclusion criteria included a reduced autonomy , which could interfere with the plethysmographic measurement , and any condition leading to water and salt retention or any severe concurrent illness . \\n all patients monitored their blood glucose and were asked to adapt the insulin doses in order to obtain hba1c close to recommended levels . \\n all patients were fully informed of the purpose of the study and gave their informed consent to take part in the investigation . \\n , all patients underwent a physical and laboratory examination to rule out any undercurrent disease . \\n when insulin therapy was indicated , the patients were invited to participate in the study and all accepted . \\n we carried out bc analysis and ms measurements at baseline , then 3 and 6 months later . \\n hba1c was measured on edta vacutainer samples by affinity chromatography using a hi - autoa1c analyzer ( a menarini diagnostics , antony cedex , france ) initially and 3 and 6 months later . \\n bw was measured on an electronic scale to the nearest 0.1 kg and height to the nearest 0.1 cm . \\n waist circumference ( wc ) at the umbilical midline was measured to the nearest mm with flexible tape . \\n air displacement plethysmographic measurements were carried out using the bod - pod body composition system ( life measurement , inc , concord , calif , usa ) according to the manufacturer 's recommendations . \\n the procedure involved the calibration of the system when empty and then when a 49.771-liter metal cylinder was placed inside . after being weighed on an electronic scale , the patients , in their undergarments and wearing a swimming cap , were seated inside the chamber and asked to remain with hands positioned on their thighs and breathing normally . \\n body volume was assessed by the difference between the volume of air inside the chamber when empty and then with the subject present . \\n if two consecutive measurements of volumes differed from each other by more than 150  ml , a third measurement was conducted . \\n body density was calculated as body weight / body volume and fat mass was calculated from the siri equation ( % fm = ( 4.950/body density)-4.500)100 . predicted respiratory volumes were taken into account in the calculations . \\n three consecutive measurements of handgrip strength with the dominant hand were performed with a calibrated dynamometer ( takei scientific instruments , tokyo , japan ) , which was reset to zero before each measurement . \\n the measurements were conducted under standardized conditions : subject seated , the shoulder adducted and neutrally rotated , with the elbow at 90 flexion and the forearm and wrist in a neutral position . \\n patients were encouraged using a standard phraseology ( squeeze the handle as hard as possible ) . \\n spss software 10.0.5 was used for the calculations ( standard version , copyright  spss inc . \\n 19891999 ) . a one - way analysis of variance for repeated measures over time ( anova ) was used to compare the values at baseline ( m0 ) , 3 months ( m3 ) , and 6 months ( m6 ) . \\n the t2d were 62  12 years , their bw was stable over the previous three months : bw 85.4  14.7  kg : bmi 30.9  5.7  kg / m , with high fm 28  10.7  kg , and wc : 105.7  12  cm , . \\n ffm was 52.4  11  kg ; and ms was 29.1  8.2  kg ; glycaemic control was poor : hba1c 9.76  1.6% . \\n glycaemic control and insulin doseshba1c improved during the first three months , and then stabilized . \\n body weight and compositionbw increased on insulin treatment to 88.5  14  kg , and 75% of the increase occurred after 3 months . \\n the composition of the bw gain : during the first three months fm and ffm were unchanged , but at six months , fm increased (   p < .012(m6/m0))whereas ffm remained unchanged , bw gain was related to changes in fm ( r = 0.83 , p < .0005 ) and wc ( r = 0.81 , p < \\n .0005 ) , but not to those of ffm(r = 0.12 , p = .63 ) . \\n bw gain was related to the initial hba1c ( r = 0.70 , p < .001 ) , to the decrease in hba1c ( r = 0.61 , p = .007 ) , and to the insulin doses ( r = 0.81 , p < .0005 ) in t2d . \\n bw increased on insulin treatment to 88.5  14  kg , and 75% of the increase occurred after 3 months . \\n the composition of the bw gain : during the first three months fm and ffm were unchanged , but at six months , fm increased (   p < .012(m6/m0))whereas ffm remained unchanged , bw gain was related to changes in fm ( r = 0.83 , p < .0005 ) and wc ( r = 0.81 , p < \\n .0005 ) , but not to those of ffm(r = 0.12 , p = .63 ) . \\n .001 ) , to the decrease in hba1c ( r = 0.61 , p = .007 ) , and to the insulin doses ( r = 0.81 , p < .0005 ) in t2d . \\n ms was correlated with ffm ( r = 0.72 , p < .0005 ) and inversely correlated with fm ( r = 0.52 , p = .001 ) . \\n in this study , we studied the progression of bw , bc , and ms during six months after starting insulin therapy in 40 t2d . insulin induced a significant decrease in hba1c , that approached the recommended level in type 2 diabetes ( 7.5 0.9% ) . \\n the course and nature of the bw gain was + 3.1  2.2  kg at m6 and 75% of the increase occurred after m3 . \\n all the weight gain was due to fm ( + 3.1  2.7  kg ) , whereas ffm was unchanged ( 0.1  1.6  kg ) and t2d did not gain ms on insulin therapy . \\n the bw gain at m6 was correlated with initial hba1c and insulin doses and with the decrease in hba1c . \\n one limitation of our study stems from the use of a two - compartment model for the analysis of bc by air displacement plethysmography ( adp ) , as hydration of ffm can not be assumed to be constant during insulin therapy . \\n overall our results are in agreement with previous studies . in t2d , previous studies reported that bw gain ( + 1.6  4.9 to + 5.2  2.7  kg at six months ) was mainly composed of fat [ 1520 ] . \\n we confirm the predominance of fm gain in insulin - treated t2d as it represented the entire bw gain ; we demonstrated for the first time the absence improvement in ms after insulin therapy in type2 diabetic patients that confirm the absence of improvement in ffm during weight gain in insulin treated t2d . \\n higher ms in type 1 diabetic patients versus t2d has been reported by cetinus et al . \\n the correlation between the decrease in hba1c and bw gain , and with insulin doses have been reported by other authors [ 18 , 20 ] . \\n our study did not aim to explain the progression of bc during insulin treatment , but several studies investigating the role of insulin on protein metabolism in diabetes mellitus have provided useful data . in type 1 diabetes , protein turnover studies using isotopically labeled amino acid tracers have demonstrated that protein breakdown and amino acid oxidation are increased in the insulin - deprived state , and are normalized by insulin , which has an anticatabolic effect . \\n the effect of insulin on protein synthesis is more difficult to explore and a matter of debate : in type 2 diabetic patients , the effect of acute administration of insulin on suppression of muscle protein breakdown was noted , but a resistance to insulin action develops on chronic administration ; a reduced nutritive blood flow may be involved in the resistance of muscular protein synthesis to the action of insulin in type 2 diabetic patients ; indeed , the response of muscle protein synthesis is impaired in the elderly , due to the inability of insulin to increase vasodilatation ; adiposity is also associated with a reduced whole - body protein anabolic action of insulin in women   and the elderly . \\n so in type 2 diabetic patients , insulin therapy can be without any effect on ffm and consequently on ms . \\n insulin therapy is clearly beneficial for glycemic control in t2d but we do not feel that the gain in fm offsets this benefit . \\n although we did not use dexa to determine the distribution of fm gain , we observed an increase in wc , which is a good indicator of visceral fm . \\n the long - term consequences of these nutritional changes need to be determined . in summary , bw gain of td2 on insulin therapy was 3.1  2.2  kg , it was predominantly fat with no improvement in muscular strength or ffm .\", 'output': 'aims . to determine the progression of body weight ( bw ) and body composition ( bc ) in patients with type 2 diabetes mellitus ( t2d ) on insulin therapy and the consequences on muscle strength ( ms ) as a reflect of free fat mass increases . \\n research design and methods . \\n we analysed bc using air displacement plethysmography and ms by hand grip dynamometry in 40 t2d before and after three ( m3 ) and six months ( m6 ) of insulin therapy . \\n results . at baseline hba1c was 9.76 1.6% and bw was stable with fat mass ( fm ) 28  10.7  kg ; and fat free mass ( ffm ) 52.4  11  kg ; at m6 , hba1c improved   to 7.56  0.8% ; insulin doses tended to increase . \\n bw gain at m6 was + 3.2  4.2  kg and with an increase of only 25% by m3 ; it was composed of fm , whereas ffm was unchanged . \\n ms did not increase on insulin therapy . \\n conclusions . in t2d , \\n bw gain was composed exclusively of fm with no improvement in ms .', '__index_level_0__': 32737}\n",
      "{'dataset': 'pubmed', 'split_data': 'test', 'task': 'summarization', 'instruction': 'Write a summary of the article that captures the main ideas and significant details.', 'input': 'complex distal humerus fractures in the elderly patients continue to be challenging for surgeons , and their prevalence is expected to increase 3-fold by 2030 . \\n although it is well - accepted that open reduction and internal fixation ( orif ) can yield satisfactory outcomes in treating these fractures , several factors can impact the surgeon s ability to achieve adequate fixation , including degree of comminution , osteoporosis , preexisting joint damage ( secondary to inflammatory conditions ) , and fracture pattern . \\n first presented by cobb and morrey in 1997 for the treatment of acute distal humerus fractures , total elbow arthroplasty ( tea ) has emerged as an alternative option even in fractures complicated by rheumatoid arthritis , osteoporosis , failed fixation , and nonunion . still , tea is not without limitations as patients must adapt to a permanent weight - bearing limitation and face potential long - term complications including infection , aseptic loosening , loss of bone stock , and periprosthetic fracture . \\n several prior studies have compared orif and tea for the treatment of distal humerus fractures ; however , sample sizes are limited . \\n recently , centers for medicare and medicaid services have initiated quality improvement programs targeting orthopedic surgery , linking health - care quality and reimbursement . as \\n such , understanding predictors of short - term outcomes and complications is becoming increasingly important . \\n the national surgical quality improvement program ( nsqip ) , a high - quality , nationally representative sample of us patients , has proven to be a aluable tool in evaluating short - term outcomes throughout orthopedics . \\n the objectives of this study were to use the nsqip database to ( 1 ) analyze and compare 30-day perioperative complication rates for primary tea and orif in elderly patients and ( 2 ) identify risk factors for complications , readmission , reoperation , and mortality . \\n the nsqip is a national surgical database that prospectively collects patient data from over 370 participating institutions . \\n all data are validated with strict adherence guidelines including routine audits to ensure high - quality data . \\n data are collected up to 30 days postoperatively including after discharge by trained clinical reviewers from medical records , operative reports , and patient interviews . \\n national surgical quality improvement program provides detailed demographics , functional status , body mass index ( bmi ) , medical comorbidities , and american society of anesthesiologists ( asa ) class . \\n intraoperative variables including wound classification , operative time , time to operation , and type of anesthesia were reviewed . \\n adverse events within the first 30 days postoperatively are tracked by nsqip and are classified as any , severe , minor , and infectious . \\n severe adverse events included death , myocardial infarction , cerebrovascular accident , renal failure , pulmonary embolism , venous thromboembolism , sepsis , septic shock , unplanned intubation , peripheral nerve injury , deep wound infection , organ / space infection , and return to operating room . \\n infectious complications including deep wound infection , superficial wound infection , organ / space infection , sepsis , or septic shock were also compiled for separate analysis . \\n a retrospective review of the american college of surgeons national surgical quality improvement program database was conducted to identify all elderly patients ( 65 years old ) who underwent either tea or orif for closed intra - articular distal humerus fractures from 2007 to 2013 . \\n inclusion criteria included patients aged 65 years or older with an intra - articular distal humerus fracture treated with either orif or tea . \\n exclusion criteria included open distal humerus fractures and patients with compromised soft tissues preoperatively corresponding to wound classes iii ( contaminated ) and iv ( dirty ) . \\n the tea cohort was identified using current procedural terminology ( cpt ) code ( 24363 ) with an associated postoperative diagnosis international classification of diseases , ninth revision ( icd-9 ) code of distal humerus fracture ( 812.2 , 812.40 , 812.41 ) . \\n the orif cohort was identified using cpt codes corresponding to orif intraarticular distal humerus fractures ( 24546 , 24579 , 24586 ) with similarly associated icd-9 codes . \\n statistical analysis was conducted using sas ( version 9.3 ) with a 2-tailed  of 0.05 . \\n bivariate analysis comparing demographics , comorbidities , and 30-day outcomes was compared between the orif and tea cohorts . \\n continuous variables were analyzed using student t test or mann - whitney u test after testing for normality and equal variance . \\n multivariate logistic regression models were built using a stepwise backward elimination approach with an exclusion p value < .20 . \\n likelihood ratio tests confirmed removed variables were not significant predictors , and all variables were assessed for confounding and interaction where appropriate . \\n among the 176 patients included in the study , there were 33 tea and 143 orif for distal humerus fracture . \\n patients who underwent tea were of similar age , gender , functional status , and bmi to those who underwent orif ( table 1 ) . \\n the majority of patients in both cohorts were classified as asa 3 or 4 and similar for both tea and orif cohorts ( 76% vs 61% , p = .11 ) . \\n operative time was 25 minutes longer in tea compared to orif , which approached significance ( p = .06 ) . \\n comparison of postoperative 30-day outcomes revealed similar frequency of adverse events in the orif ( 8.4% ) and tea ( 12% ) groups ( table 2 ) . \\n severe adverse events were more common in tea compared to orif , however , this did not achieve statistical significance ( 21% vs 12% , p = .24 ) . \\n total elbow arthroplasty was associated with a significantly increased postoperative length of stay compared to orif ( 3.6 days vs 2.3 , p = .03 ) . \\n the most common severe adverse events were unplanned return to operating room ( 2.1% orif , 3.0% tea ) , stroke ( < 1% orif , 3.0% tea ) , and myocardial infarction ( orif 1.4% , 0% tea ) . comparison of patient demographic characteristics . \\n abbreviations : asa class , american society of anesthesiology class ; bmi , body mass index ; sd , standard deviation . \\n abbreviations : cva , cerebrovascular accident ; cpr , cardiopulmonary resuscitation ; dvt , deep vein thrombosis ; pe , pulmonary embolism ; sd , standard deviation . \\n unique number of patients with severe or minor adverse event . \\n unique number of patients with superficial surgical site infection , deep surgical site infection , organ / space infection , sepsis , or septic shock . \\n multivariate logistic regression analysis revealed that tea compared to orif was associated with a nonsignificantly increased odds of any adverse event ( odds ratio [ or ] 1.13 , p = .35 ) and severe adverse event ( or 1.57 , p = .16 ) ( table 3 ) . \\n independent predictors of any adverse event included functional status ( or 1.82 , p = .04 ) and insulin - dependent diabetes ( or 2.45 , p = .03 ) 6 . \\n disabilities of the arm , shoulder and hand insulin - dependent diabetes ( or 1.95 , p = .02 ) was also an independent predictor of severe adverse events . \\n this study used the nsqip database to compare 30-day surgical outcomes after treatment of closed distal humerus fractures in patients older than 65 years with tea and orif . \\n importantly , the sample size achieved ( 176 patients ) is one of the largest studies to date comparing tea and orif . \\n moreover , the centers that participate in nsqip are an approximate representation of us medical centers , making our findings generalizable . \\n the analysis suggests that short - term rate of severe adverse events , including infection and unplanned readmission , does not differ significantly between patients treated with tea or orif . \\n in contrast to this study , most existing literature focuses upon orthopedic and functional outcomes rather than medical and surgical complication rates of distal humerus fractures . \\n multiple retrospective and small prospective studies have shown that tea has equivalent or improved outcomes compared with orif for distal humerus fractures in select patient populations . \\n frankle et al were the first to report better results with total elbow arthroplasty than with internal fixation in a study of 24 patients . \\n they suggest that patients treated with tea had better outcomes in terms of pain , range of motion , patient satisfaction , and rates of reoperation . \\n furthermore , 2 additional retrospective studies by jost et al ( 14 patients ) and egol et al ( 20 patients ) found no significant difference in functional outcome , range of motion , or pain , though mayo elbow performance scores ( meps ) were higher on average for the tea group . collectively , the 3 retrospective studies recommended tea for elderly patients with rheumatoid arthritis , osteoporosis , or chronic conditions requiring systemic steroids . \\n the socit orthopdique de louest also confirmed these results , reporting better meps and disabilities of the arm , shoulder and hand ( dash ) scores in tea than in orif . in that study , complications occurred in 14% in tea ( reoperation rate 6% ) compared to 20% in orif ( reoperation rate 13% ) . despite the analysis of 238 cases , \\n building on the notion that tea provides better outcomes , mckee et al conducted a randomized prospective study in 2009 involving 42 patients . \\n they found that the tea patients had immediate stability , earlier mobilization with faster rehabilitation , and better short - term functional outcomes in a subset of elderly patients with osteoporosis . \\n the meps was better in patients treated with tea at all - time points up to 2 years . \\n the dash score was better early on , but that trend reversed by 2-year follow - up . \\n the rate of revision in the tea group was 12% versus 27% in the orif group . \\n in the same study , 25% of the orif patients were converted to tea due to intraoperative findings , highlighting the need for a standardized algorithm to guide surgeon decision making in treating these fractures . \\n multivariate analysis revealed insulin - dependent diabetes and functional status to be independent predictors of adverse events after tea and orif . \\n the importance of addressing modifiable risk factors such as diabetes prior to surgery is generally agreed upon and is currently being tested through models such as the perioperative surgical homes , however , we recognize this may not always be possible for elderly patients undergoing emergency orif or tea . \\n our finding regarding functional status is consistent across major orthopedic procedures as illustrated by pugley et al and basques et al who analyzed 19 800 primary hip / knee replacement and 4400 ankle orif patients and found functional status to be an independent risk factor for short - term complications and unplanned readmission . \\n furthermore , looking across specialties , hoyer et al analyzed 9405 patients to show that functional status during the postoperative inpatient stay is an independent predictor for 30-day readmission . \\n though dependent functional status is often multifactorial , it could be managed pre- and postoperatively using several strategies including setting up a perioperative surgical home to develop a customized care plan for the patient well before surgery or utilizing hospital - based exercise programs to allow early mobilization during the postoperative stay . \\n  beyond addressing modifiable risk factors , \\n intraoperative soft - tissue management is critical to limiting complications as distal humerus fractures in elderly patients frequently present with a compromised soft - tissue envelope . given this context and a desire to minimize any further risk of infection , surgeons may be hesitant to treat these fractures with tea given the high historical infection rate in elective tea . \\n for closed distal humerus fractures without compromised tissue envelop , our analysis found a very low infection rate overall without any meaningful difference in infections up to 30 days postprocedure . in our study , \\n operative time was longer in the tea group ( 165 minutes vs 140 minutes , p = .06 ) . \\n these findings are in contradistinction to mckee et al who note that operative time in tea was significantly shorter than orif ( 140 minutes vs 108 minutes , p = .01 ) . \\n this may reflect either that treating surgeons were unfamiliar with tea instrumentation or failed initial intraoperative attempts at orif , which mckee et al describe in 25% of attempted orif . limiting operative time is a modifiable surgeon - dependent risk factor and has similarly been established as a predictor of infection in ankle and tibial plateau fractures . \\n these findings suggest that the intraoperative decision to convert from orif to tea should be made decisively . \\n surgeons seeking to perform tea for fractures in the elderly patients should ensure they are proficient with the surgical technique and equipment of tea . \\n additionally , preoperative rehearsal , practice , and prior experience all serve to streamline operations and make them more time efficient . \\n an additional point of interest identified in our analysis was the length of stay is longer for the tea group . \\n the reasoning behind this fact is unclear , as medical comorbidities and functional status were similar in both orif and tea groups as well as complication rates . \\n perhaps , increased length of stay may reflect limited provider experience with tea versus orif . \\n this database is not an orthopedic - specific database and functional outcomes are not collected , however , the relevance of nsqip throughout orthopedics has been widely established . \\n additionally , late complications of tea such as triceps insufficiency and loosening are not captured in our analysis . \\n however , our study establishes several relevant short - term complications such as perioperative medical complication , transfusion , and readmission . \\n although inclusion was limited to intra - articular distal humerus fractures with the same icd-9 codes , exact radiographic fracture classification can not be compared between cohorts . at the same time , \\n usage trends of tea have shown that fracture has rapidly overtaken inflammatory conditions suggesting that indications for tea in fracture are expanding and are likely no longer confined to most severely comminuted fractures . \\n lastly , our data do not capture functional outcomes , which determine whether a treatment is actually successful . \\n multiple studies have compared the functional outcome of tea versus orif and found both to be favorable . \\n our study suggests a similar short - term complication profile of orif and tea for distal humerus fractures in elderly patients . \\n independent risk factors of short - term complications including insulin - dependent diabetes and dependent functional status should be targeted to reduce postoperative complication rates . \\n although tea has gained the reputation of being a faster more reliable option to orif in certain studies , our findings in a national validated database may indicate otherwise .', 'output': 'background : the purpose of this study was to evaluate 30-day postoperative complications of open reduction and internal fixation [ orif ] and total elbow arthroplasty [ tea ] for the treatment of distal humerus fractures in elderly patients using a validated national database.methods:review of the national surgical quality improvement program ( nsqip ) database identified all elderly patients ( > 65 years ) who underwent tea or orif for the treatment of closed intra - articular distal humerus fractures from 2007 to 2013 . \\n bivariate and multivariate analyses of risk factors for 30-day adverse events as defined by nsqip between orif and tea groups were assessed using preoperative and intraoperative variables.results:among the 176 patients with distal humerus fractures , there were 33 tea and 143 orif . \\n there was no difference in age , medical comorbidities , or functional status . \\n total elbow arthroplasty was associated with an increased odds of severe adverse event compared to orif ( odds ratio = 1.57 , p = .16 ) , although it did not achieve statistical significance . \\n infection rate was 0.7% in orif and 0.0% in tea ( p = .99 ) . \\n insulin - dependent diabetes and functional status were significant independent predictors of postoperative adverse events . \\n operative time ( 165 minutes vs 140 minutes , p = .06 ) and postoperative length of stay ( 3.6 days vs 2.3 days , p = 0.03 ) were longer for tea compared to orif.conclusion:open reduction and internal fixation and tea have similar 30-day postoperative complications for the treatment of distal humerus fractures among elderly patients . despite favorable trends for tea in recent studies , \\n additional clinical results are needed to understand complications and limitation of tea.level of evidence : level iii , prognostic study .', '__index_level_0__': 32338}\n",
      "Task: relation_extraction, Sampled: 50\n",
      "{'dataset': 'ddi', 'split_data': 'test', 'task': 'relation_extraction', 'instruction': \"Analyze the sentence with two drugs labeled as @DRUG_A$ and @DRUG_B$. Extract the interaction between @DRUG_A$ and @DRUG_B$ from the input sentence by selecting only one of the following options: 'DDI-effect', 'DDI-mechanism', 'DDI-advise', 'DDI-false', and 'DDI-int'. 'DDI-effect': Choose this when the interaction describes an effect or a pharmacodynamic mechanism. 'DDI-mechanism': Choose this for interactions explained by pharmacokinetic mechanisms. 'DDI-advise': Choose this when the sentence provides a recommendation or advice about the drug interaction. 'DDI-false': Choose this if there is no actual drug-drug interaction in the sentence. 'DDI-int': Choose this when a drug-drug interaction is mentioned without additional detail.\", 'input': 'The following are examples of substances that may reduce the blood-glucose-lowering effect of insulin: corticosteroids, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, albuterol, @DRUG_A$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG_B$, progestogens (e.g., in oral contraceptives).', 'output': 'DDI-false', '__index_level_0__': 31569}\n",
      "{'dataset': 'ddi', 'split_data': 'test', 'task': 'relation_extraction', 'instruction': \"Analyze the sentence with two drugs labeled as @DRUG_A$ and @DRUG_B$. Extract the interaction between @DRUG_A$ and @DRUG_B$ from the input sentence by selecting only one of the following options: 'DDI-effect', 'DDI-mechanism', 'DDI-advise', 'DDI-false', and 'DDI-int'. 'DDI-effect': Choose this when the interaction describes an effect or a pharmacodynamic mechanism. 'DDI-mechanism': Choose this for interactions explained by pharmacokinetic mechanisms. 'DDI-advise': Choose this when the sentence provides a recommendation or advice about the drug interaction. 'DDI-false': Choose this if there is no actual drug-drug interaction in the sentence. 'DDI-int': Choose this when a drug-drug interaction is mentioned without additional detail.\", 'input': 'Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG_A$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG_B$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.', 'output': 'DDI-false', '__index_level_0__': 31540}\n",
      "{'dataset': 'ddi', 'split_data': 'test', 'task': 'relation_extraction', 'instruction': \"Analyze the sentence with two drugs labeled as @DRUG_A$ and @DRUG_B$. Extract the interaction between @DRUG_A$ and @DRUG_B$ from the input sentence by selecting only one of the following options: 'DDI-effect', 'DDI-mechanism', 'DDI-advise', 'DDI-false', and 'DDI-int'. 'DDI-effect': Choose this when the interaction describes an effect or a pharmacodynamic mechanism. 'DDI-mechanism': Choose this for interactions explained by pharmacokinetic mechanisms. 'DDI-advise': Choose this when the sentence provides a recommendation or advice about the drug interaction. 'DDI-false': Choose this if there is no actual drug-drug interaction in the sentence. 'DDI-int': Choose this when a drug-drug interaction is mentioned without additional detail.\", 'input': 'Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG_A$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG_B$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.', 'output': 'DDI-false', '__index_level_0__': 31513}\n",
      "{'dataset': 'ddi', 'split_data': 'test', 'task': 'relation_extraction', 'instruction': \"Analyze the sentence with two drugs labeled as @DRUG_A$ and @DRUG_B$. Extract the interaction between @DRUG_A$ and @DRUG_B$ from the input sentence by selecting only one of the following options: 'DDI-effect', 'DDI-mechanism', 'DDI-advise', 'DDI-false', and 'DDI-int'. 'DDI-effect': Choose this when the interaction describes an effect or a pharmacodynamic mechanism. 'DDI-mechanism': Choose this for interactions explained by pharmacokinetic mechanisms. 'DDI-advise': Choose this when the sentence provides a recommendation or advice about the drug interaction. 'DDI-false': Choose this if there is no actual drug-drug interaction in the sentence. 'DDI-int': Choose this when a drug-drug interaction is mentioned without additional detail.\", 'input': 'Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG_A$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG_B$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.', 'output': 'DDI-false', '__index_level_0__': 31493}\n",
      "{'dataset': 'ddi', 'split_data': 'test', 'task': 'relation_extraction', 'instruction': \"Analyze the sentence with two drugs labeled as @DRUG_A$ and @DRUG_B$. Extract the interaction between @DRUG_A$ and @DRUG_B$ from the input sentence by selecting only one of the following options: 'DDI-effect', 'DDI-mechanism', 'DDI-advise', 'DDI-false', and 'DDI-int'. 'DDI-effect': Choose this when the interaction describes an effect or a pharmacodynamic mechanism. 'DDI-mechanism': Choose this for interactions explained by pharmacokinetic mechanisms. 'DDI-advise': Choose this when the sentence provides a recommendation or advice about the drug interaction. 'DDI-false': Choose this if there is no actual drug-drug interaction in the sentence. 'DDI-int': Choose this when a drug-drug interaction is mentioned without additional detail.\", 'input': 'The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and @DRUG_A$ (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (@DRUG_B$) and model peptide drugs, bacitracin and insulin.', 'output': 'DDI-false', '__index_level_0__': 31458}\n",
      "Task: qa_objective_3, Sampled: 50\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Does plasma adiponectin play an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects? Context: We investigated the effect of glimepiride, a third-generation sulfonylurea hypoglycemic agent, on insulin resistance in elderly patients with type 2 diabetes, in connection with plasma adiponectin and 8-epi-prostagrandin F2alpha (8-epi-PGF2alpha), an oxidative stress marker. A total of 17 elderly patients with type 2 diabetes received 12 weeks of treatment with glimepiride. Homeostasis assessment model of insulin resistance (HOMA-IR), homeostasis assessment model of beta-cell function, HbA(1c), C-peptide in 24-h pooled urine (urine CPR), and plasma concentrations of 8-epi-PGF2alpha, tumor necrosis factor-alpha (TNF-alpha), plasminogen activator inhibitor type 1, and adiponectin were measured at various times. The metabolic clearance rate of glucose (MCR-g) was also assessed by a hyperinsulinemic-euglycemic clamp. After 8 weeks of glimepiride treatment, significant reductions were observed in HbA(1c) (from 8.4 +/- 1.9 to 6.9 +/- 1.0%), HOMA-IR (from 2.54 +/- 2.25 to 1.69 +/- 0.95%), and plasma TNF-alpha concentrations (from 4.0 +/- 2.0 to 2.6 +/- 2.5 pg/ml). MCR-g was significantly increased from 3.92 +/- 1.09 to 5.73 +/- 1.47 mg. kg(-1). min(-1). Plasma adiponectin increased from 6.61 +/- 3.06 to 10.2 +/- 7.14 micro g/ml. In control subjects, who maintained conventional treatment, no significant changes were observed in any of these markers.', 'output': 'yes', '__index_level_0__': 32190}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Is thiazolidinedione use associated with worse cardiovascular outcomes : a study in 28,332 high risk patients with diabetes in routine clinical practice : brief title : thiazolidinedione use and mortality? Context: Assess the cardiovascular safety of Thiazolidinediones (TZD) in routine clinical practice. TZD are insulin-sensitizing antidiabetic drugs commonly used in type 2 diabetes, but their cardiovascular safety has been questioned. We examined the association between TZD use and major cardiovascular outcomes. We examined 2-year mortality, non-fatal myocardial infarction (MI), and congestive heart failure (CHF) rates among outpatients with high cardiovascular risk and diabetes according to TZD use in the REACH Registry. Multivariable adjustment and propensity scores were used in the analyses. A total of 4997 out of 28,332 patients took TZDs at baseline. During follow-up, 1532 patients died. The mortality rates (95% confidence interval [CI]) were 6.5% (5.5-7.6) with TZD and 7.2% (6.33-8.06) without; adjusted hazard ratio (HR) was 1.06 (0.89-1.26, P=0.54). The lack of association with mortality was consistent across subgroups regardless of history of atherothrombosis or CHF. Rates of non-fatal MI (HR 1.10, 95% CI 0.83-1.45, P=0.50) and non-fatal CHF (HR 0.90, CI 0.75-1.09, P=0.27) were similar in users and non-users. TZD use was associated with an increased risk of CHF in patients aged >80 years (HR 1.59, CI 1.06-2.40, P=0.03).', 'output': 'no', '__index_level_0__': 32241}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Is high red blood cell folate associated with an increased risk of death among adults with diabetes , a 15-year follow-up of a national cohort? Context: To describe the mortality and fatality of diabetes and assess their relationship with the level of red blood cell (RBC) folate. We analyzed the data of 526 adults with diabetes who participated in the National Health and Nutrition Examination Survey (1991-1994) as the baseline examination, and were followed up through December 31, 2006. Estimates of the hazard ratios (HRs) of selected death causes for individuals with different levels of RBC folate were obtained from Cox proportional hazards regression. A total of 295 deaths were recorded by the end of a 15-year follow-up with a mortality rate of 58.48 per 1000 person year (py). Diabetes was listed as a contributing cause for 136 deaths, accounting for 46.1% of the total deaths with a fatality rate 26.96 per 1000\\xa0py. Mortality rate for all-cause in the group with upper quartile of RBC folate was almost twice as high as that among the group with lower quartile, 82.75 vs. 44.10 per 1000\\xa0py. After adjusting for covariates, including serum concentration of vitamin B12, cotinine, homocysteine and the history of cardio-cerebral vascular diseases assessed at the baseline, the HRs for dying from any causes were 1.00 (reference), 1.82 (95% CI\\xa0=\\xa01.25-2.66) and 2.10 (1.37-3.20) among diabetic adults with lower, intermediate, and upper quartiles of RBC folate.', 'output': 'yes', '__index_level_0__': 32161}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Does modest decrease in PGC1Î± result in TAG accumulation but not in insulin resistance in L6 myotubes? Context: PGC-1Î± is an important cellular protein (coactivator) regulating myocyte mitochondria number and function, and therefore whole cellular energy status. The aim of this work was to investigate the effects of modest, temporary PGC-1Î± knock-down on L6 myotubes insulin resistance in a light of cellular lipid metabolism. Gas liquid chromatography was applied for assessing FAs content and composition. For the expression of mitochondrial enzymes, as well as FA and glucose transporters, Western Blot technique was adopted. Additionally, radiolabelled glucose and palmitic acid uptake was performed to estimate the nutrients cellular influx. Modest (-24%) PGC-1Î± protein ablation resulted in decreased mitochondrial activity in general (reduced Cyt C content) and FAs oxidation in particular (diminished Î²-HAD expression) without increased FAs cellular influx. The aforementioned intervention led to significantly increased TAG cellular level, but not DAG nor CER. Consequently, no changes in cellular insulin responsiveness were noticed.', 'output': 'yes', '__index_level_0__': 32141}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Do gAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes? Context: Autoantibodies to insulin and GAD are features of preclinical type 1 diabetes in children. For insulin autoantibodies, the antibody affinity and epitope specificity predict which children progress to diabetes. We asked whether autoantibodies to GAD (GADAs) are heterogeneous in affinity and epitope recognition and whether diabetes-related GADA are restricted to high-affinity responses. GADA affinity was measured by competitive binding experiments with [(125)I]-labeled and -unlabeled recombinant human GAD65 in the first GADA-positive sample from 95 children with a type 1 diabetes family history who were prospectively followed from birth and in follow-up samples from 65 of these children. At first GADA appearance, affinity ranged from 10(7) to 10(10) l/mol. Affinity was higher in multiple islet autoantibody-positive children (P < 0.0001) and in HLA DR3-positive children (P = 0.006). GADA affinities were >10(9) l/mol in 52 of 53 multiple autoantibody-positive children. In contrast, children who were single GADA positive often had lower affinity GADA and/or GADA with specificities that were restricted to minor NH(2)-terminal GAD65 epitopes. At follow-up, affinity increased from low to high in 3 of 65 children. All 24 children who developed diabetes had high-affinity GADAs before diabetes onset.', 'output': 'yes', '__index_level_0__': 32148}\n",
      "Task: qa_objective_2, Sampled: 50\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'Which of the following compound antagonizes the actions of insulin Please select one of the following: A) Neuropeptide Y, B) Growth hormone, C) Substance P, D) Vasoactive intestinal peptide.', 'output': 'B) Growth hormone', '__index_level_0__': 31708}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 36-year-old male presents because his skin has been darkening recently. You notice that his skin has a dark, somewhat bronze color. Workup reveals signs of diabetes mellitus. His serum iron is found to be 1150 mg/dL, and his transferrin saturation is 98%. A liver biopsy is performed and reveals extensive deposits of hemosiderin in the hepatocytes and Kupffer cells. The mechanism most likely responsible for this constellation of findings is Please select one of the following: A) Defective excretion of copper into the bile, B) Defective synthesis of a1 antitrypsin, C) Excessive reabsorption of iron from the small intestines, D) Excessive absorption of galactose from the small intestines.', 'output': 'C) Excessive reabsorption of iron from the small intestines', '__index_level_0__': 31654}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'Which of the following is true regarding successful whole- organ pancreas transplantation in type I diabetes? Please select one of the following: A) It results in maintenance of normal serum glucose levels, B) Recurrence of diabetic nephropathy in simultaneously transplanted kidneys is not prevented, C) Oral glucose tolerance tests remain abnormal, D) The pathologic changes of diabetic retinopathy are reversed.', 'output': 'D) The pathologic changes of diabetic retinopathy are reversed', '__index_level_0__': 31728}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 73-year-old woman with a history of diabetes presents with left ear pain and drainage of pus from the ear canal. She has a swelling and tenderness over the left mastoid bone. Which of the following microorganisms is the MOST likely causative agent? Please select one of the following: A) Hemophilus influenzae, B) Klebsiella pneumoniae, C) Mucor sp., D) Pseudomonas aeruginosa.', 'output': 'D) Pseudomonas aeruginosa', '__index_level_0__': 31663}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'Lipid profile in diabetes is A/E - Please select one of the following: A) Decreased TG, B) Increased HDL, C) increased LDL, D) decreased Cholesterol.', 'output': 'C) increased LDL', '__index_level_0__': 31733}\n",
      "Task: generation, Sampled: 42\n",
      "{'dataset': 'icliniq', 'split_data': 'test', 'task': 'generation', 'instruction': \"Generate a comprehensive medical response based on the patient's query.\", 'input': 'Hi doctor,My mother is 62 years old. She has purple-like patches on her arms and legs as shown in the attached picture. She said that she has it for over three to four years and these patches fade in a few days once they appear. My mother also has diabetes and hypertension. She is using some antibiotics for diabetes and hypertension. She also has substernal goiter and her biopsy was negative. I am attaching her blood and hormone results, which are in the normal range. Liver function tests were also normal. What are these fading purple-like patches?', 'output': 'Hi, Welcome to Chat Doctor forum. I have gone through the pictures and reports (attachment removed to protect patient identity). 1. Blood thinner agent.2. Minor trauma. Bleeding time and clotting time. 1. Ecchymosis.2. Senile purpura. Revert back after a week to a dermatologist online.-', '__index_level_0__': 31611}\n",
      "{'dataset': 'icliniq', 'split_data': 'test', 'task': 'generation', 'instruction': \"Generate a comprehensive medical response based on the patient's query.\", 'input': 'Hi doctor,I am a 33 year old female. I have never smoked. I am not overweight and I do not have diabetes. I have been having some left leg issues. It started six months back. I started limping because my left calf, ankle and groin were hurting. My emergency Doppler venous ultrasound was clear. I had a D-dimer and that was negative. I had an MRI of my left ankle that showed a talofibular ligament sprain on my left ankle. I also had an arterial Doppler ultrasound that showed decreased flow of left anterior tibial artery and increased peak systolic velocity in the left common femoral artery. But, there was no stenosis, no sclerosis and no plaque. Could the sprain have caused that decreased flow? After three months, it became normal again. Then, while having pedicure the woman massaged my ankle and leg. Since then the pain has returned to my left ankle and left leg. I had another D-dimer done three weeks ago that was negative. I have also recently started experiencing cold left foot and a left cold lower leg at night. By morning, both the legs as well as the feet are of the same temperature. I do get pain in the buttocks and the pain is going down my leg like a sciatic pain on the left leg. Do I have peripheral artery disease? Could a blood clot be causing it? I have a four hours flight next week and I am worried about flying. Is it safe to fly? Would the arterial Doppler and D-dimer be able to tell if I have a blood clot in my artery? Or is a D-dimer just for the veins? My LDL was 10 points above normal in my last blood test. But, my doctor did not seem to be concerned as my HDL was high. I have attached the reports for your reference. Please help me.', 'output': 'Hi, Welcome to Chat Doctor forum. From your description, I understand that the first time you had a problem with your left leg was due to a sprain (talofibular ligament) around the ankle and it got resolved. I suspect the same problem or something similar is causing you the pain again. It is highly unlikely for a 33 year old lady and a non-smoker to have a peripheral vascular disease. The arterial Doppler did show a decreased blood flow, but it might be due to a temporary spasm of the vessel than any specific pathology or disease. Moreover, no clot was found nor was there any change suggesting peripheral vascular disease. It is absolutely safe to fly and you need not worry about it. An arterial Doppler will be able to make out if you have a clot. D-dimer test is only for the veins and is not useful in arterial disease. I suggest you to look for causes either in your footwear or any strain which you have put repeatedly on your ankle causing repeated sprain in the left ankle. You can get an orthopedic consultation to be sure of the same. If he or she does not find any problem and your pain persists even after appropriate treatment then further evaluation can be done by a vascular surgeon. But, I do feel you may not require it.', '__index_level_0__': 31601}\n",
      "{'dataset': 'icliniq', 'split_data': 'test', 'task': 'generation', 'instruction': \"Generate a comprehensive medical response based on the patient's query.\", 'input': \"I'm 40 & I've had glandular fever, shingles, influenza and have an autoimmune condition (Hashimoto's disease). I believe I may be more vulnerable than the average person my age to get Coronavirus, due to my weakened immune system? Should I be self isolating? I am ok to do so\", 'output': 'Hello! Thank you for reaching out I understand. Bases on the available data, those who are 60 above, and with medical condition such as hypertension, cardiovascular disease and diabetes are the most vulnerable population. Thyroid disease and any other autommine condition is not known to be associated with increased risk of viral infections in general, nor is there an association between these disease and severity of the viral infection However, if you mild symptoms of cough and fever, I would still recommend that you do self quarantine and monitoring. I would still recommend that you wash your hands regularly with alcohol, soap and water and practice social distancing. I hope i wa able to answer your concern. Is there anything else I can help you with?', '__index_level_0__': 31612}\n",
      "{'dataset': 'icliniq', 'split_data': 'test', 'task': 'generation', 'instruction': \"Generate a comprehensive medical response based on the patient's query.\", 'input': 'Hello doctor,I am a 25-year-old lady about 6 to 7 weeks pregnant. My HbA1c is 12. What should I do?', 'output': 'Hi, Welcome to Chat Doctor forum. According to diabetes guidelines, the patient should have strict diabetic control pre-pregnancy. It is better to have a strict diabetic diet and sugar levels within the normal range and have HbA1c less than 6. Frankly speaking, I feel that during conception, less than 6 or 5 would be better but at 10, it is advised not to conceive but I think after conception it would have increased. As with high sugar levels, more chances of congenital anomalies in the fetus are there, most popular is heart defects. The baby could have diabetes and could grow fast due to sugar levels imbalance and can be large for the gestational age. It can have stillbirth, difficult delivery, intrauterine death, etc. Please contact maternal medicine consultant obstetrician and discuss your detailed history and treatment till now. In pregnancy, Insulin is preferred over oral medications. Have a strict diabetic diet, daily walk, yoga, or mild exercises. Try to have strict monitoring of fetus as well as your sugar levels. Things could be well only with strict diabetic treatment and precautions for the whole pregnancy.', '__index_level_0__': 31623}\n",
      "{'dataset': 'icliniq', 'split_data': 'test', 'task': 'generation', 'instruction': \"Generate a comprehensive medical response based on the patient's query.\", 'input': 'Hello doctor,I am a 29 year old male. I have a family history of diabetes, hypertension, and heart disease. I have been experiencing intermittent chest, left arm and left shoulder pain/discomfort with periods of breathlessness for about two years now. I have had ECGs done on a few occasions and doctors said its unremarkable and commented that the main is orthopedic or neurological in nature. I have consulted a few reputed orthopedic and neurologic doctors and had subsequent MRIs, X-Rays, EMG and NCV done and all reports were normal. The pain was intermittent meanwhile. For the last three months the discomfort became worse. One doctor advised me to get a Cardiac CT done. The result of that showed a myocardial bridge. I have a history of high cholesterol and was under statins for three years now. They have subscribed a beta blocker as well. I would like to know more about the condition. The report and CT image are attached. Looking forward to your opinion.', 'output': 'Hello, Welcome to Chat Doctor forum. Myocardial bridging - In your case, one of the heart artery LAD, the mid portion, passes through the cardiac muscles instead of lying on the wall. In the activity, when your heart rate increases due to this problem the blood flow reduce and causes discomfort to you. You try to avoid strenuous activities. With medicine, you will feel better but avoid strenuous activities. For more information consult a cardiologist online', '__index_level_0__': 31626}\n",
      "Task: nli, Sampled: 50\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Insulin signaling in the liver blunts glucose production and stimulates triglyceride biosynthesis. FoxO1 is required for cAMP induction of hepatic glucose production and is permissive for the effect of insulin to suppress this process. Moreover, FoxO1 ablation increases lipogenesis. In this study, we investigated the pleiotropic actions of FoxO1 on glucose and lipid metabolism. To this end, we reconstituted FoxO1 function in mice with a liver-specific deletion of Foxo1 using targeted knock-in of an allele encoding a DNA binding-deficient FoxO1 mutant (L-DBD). Chow-reared L-DBD mice showed defects in hepatic glucose production but normal liver triglyceride content despite increased rates of de novo lipogenesis and impaired fatty acid oxidation in isolated hepatocytes. Gene expression studies indicated that FoxO1 regulates the expression of glucokinase via a cell-nonautonomous coregulatory mechanism, while its regulation of glucose-6-phosphatase proceeds via a cell-autonomous action as a direct transcriptional activator.', 'output': 'entailment', '__index_level_0__': 31415}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] A 32-year-old woman presented with a 10-day history of fever (38.0 degrees C), headaches, nausea, vomiting and a 6-month history of diabetes insipidus and amenorrhoea. Two months previously she had undergone a surgical drilling of the right mastoid area because of mastoiditis. Endocrine investigation showed elevated serum prolactin levels, secondary adrenal and gonadal failure and a normal thyroid function. Cranial MRI scan revealed a contrast enhancing intrasellar mass (approximately 2 cm) of heterogeneous appearance with suprasellar extension and thickening of the pituitary stalk. Lumbar puncture was suggestive of aseptic meningitis. The Ziehl-Neelsen stain of cerebrospinal fluid (CSF) and the tuberculin skin test were both negative. The pituitary mass was removed with a transsphenoidal approach. Histological examination demonstrated destruction of the adenohypophysis by epithelioid granulomas with partial caseous necrosis and microabscess formation, suggestive of a mycobacterial infection. A polymerase chain reaction analysis performed on paraffin-embedded tissue was positive for mycobacterial DNA. According to the individual 16S sequence, it was identified as Mycobacterium malmoense, an atypical nontuberculous mycobacterium (NTM).', 'output': 'contradiction', '__index_level_0__': 31426}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Alcohol abusers often present with deteriorated glucose metabolism and insulin resistance. Changes in other glucoregulators, such as insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 (IGFBP-1) may also be related to alcohol abuse. We studied the effects of alcohol withdrawal on blood glucose, serum insulin and C-peptide, and plasma IGF-I and IGFBP-1 levels in 27 noncirrhotic male alcoholics aged 43 +/- 9.0 (mean +/- SD) years on four consecutive days immediately after withdrawal. A 4-day monitoring period was conducted in four healthy nonalcoholic control men. The groups were similar in age and body mass index. Glucose, insulin, IGF-I, and IGFBP-1 did not differ significantly between the groups at the baseline, but C-peptide was higher in alcoholics (p < 0.01). After alcohol withdrawal, serum insulin and C-peptide levels increased in close correlation with each other (r = 0.82, p < 0.001). During the 4-day observation period in alcoholics, IGFBP-1 levels declined by 59%, whereas IGF-I increased by 41% (p < 0.001 for both comparisons). The change in insulin correlated inversely with the change in IGFBP-1 levels (r = -0.39, p < 0.05). In the control group, glucose, insulin, IGF-I, and IGFBP-1 remained unchanged during the 4-day monitoring period, whereas some reduction was observed in C-peptide.', 'output': 'contradiction', '__index_level_0__': 31410}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': \"[PRE] It is known that follicle-stimulating hormone (FSH) and insulin stimulate estradiol secretion from cultured non-luteinizing granulosa cells. The interaction between these hormones is less well understood. Granulosa cells from small (2-4 mm) bovine follicles were cultured in serum-free medium to determine if cytochrome P450 aromatase activity is regulated by FSH in the presence of different concentrations of insulin. Insulin significantly stimulated aromatase activity in the absence of FSH. There was a significant interaction between insulin and FSH on aromatase activity, such that FSH stimulated activity at low (0.5, 1 and 10 ng/ml) doses of insulin, whereas at higher (100 ng/ml) doses of insulin FSH failed to stimulate aromatase activity. To determine if the lack of a response to FSH with higher doses of insulin is related to gene expression, the effect of FSH on P450 aromatase mRNA levels was measured. An 'uncoupling' of mRNA and enzyme activity was observed for cells cultured with 100 ng/ml insulin, as FSH significantly increased P450 aromatase mRNA abundance without affecting estradiol secretion or aromatase activity.\", 'output': 'contradiction', '__index_level_0__': 31397}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Severe reproductive dysfunction has been described in non-insulin-dependent diabetes mellitus (NIDDM), correlated with high glucose levels in the plasma. We have characterized an abnormal prostanoid profile in tissues from NIDDM rats, and a tight correlation between nitric oxide (NO) levels and prostaglandin production. Likewise, we have determined that parturition is delayed in NIDDM rats compared to control animals. In order to characterize the events which precede delayed parturition in NIDDM rats, we evaluate (a) the arachidonic acid (AA) conversion in placental tissue obtained from control (day 21 and 22) and NIDDM (day 21, 22 and 23) late pregnant rats into prostaglandin E2 (PGE2) and F2alpha (PGF2alpha), thromboxane B2 (TXB2) and 6-keto-prostaglandin F1alpha (6-keto-PGF1alpha), and (b) NO synthase (NOS) activity in control and NIDDM late pregnant animals. Placental arachidonate conversion from control rats into different prostanoids, namely PGE2, PGF2alpha, and TXB2, is higher in day 22 than in day 21, and radioconversion from diabetic rats into PGE2, PGF22, TXB2 and 6-keto-PGF1alpha on day 23 is higher than in day 21 and 22. 6-keto-PGF1alpha is lower and TXB2 is higher in diabetic tissues than in control. Placental AA conversion of control diabetic tissues on the day of delivery is decreased by N(G) monomethyl-L-arginine (LNMMA) (600 mM), a well known NOS inhibitor, while prostanoid production remains unaltered on previous days. NOS activity is higher in control on day 22 when compared to day 21, and in diabetic on day 23 when compared to day 22 of pregnancy.', 'output': 'contradiction', '__index_level_0__': 31417}\n"
     ]
    }
   ],
   "source": [
    "import random\n",
    "import numpy as np\n",
    "import pandas as pd  # pandas ìž„í¬íŠ¸ ì¶”ê°€\n",
    "from datasets import load_dataset, Dataset, DatasetDict\n",
    "\n",
    "# ì‹œë“œ ê°’ ì„¤ì •\n",
    "SEED = 42\n",
    "\n",
    "# Pythonì˜ random ëª¨ë“ˆ ì‹œë“œ ê³ ì •\n",
    "random.seed(SEED)\n",
    "\n",
    "# NumPy ì‹œë“œ ê³ ì •\n",
    "np.random.seed(SEED)\n",
    "\n",
    "# 1. ë°ì´í„°ì…‹ ë¡œë“œ\n",
    "dataset_name = \"passionMan/diabetes_v10\"\n",
    "train_dataset = load_dataset(dataset_name, split=\"train\")\n",
    "test_dataset = load_dataset(dataset_name, split=\"test\")\n",
    "\n",
    "# 2. ì¤‘ë³µ í™•ì¸ì„ ìœ„í•œ train ë°ì´í„°ì˜ (input, output) ì„¸íŠ¸ ìƒì„±\n",
    "train_pairs = set((row[\"input\"], row[\"output\"]) for row in train_dataset)\n",
    "\n",
    "# 3. ê° taskë³„ ìƒ˜í”Œ ê°œìˆ˜ ì„¤ì •\n",
    "task_sample_limits = {\n",
    "    'qa_objective_1': 50,\n",
    "    'qa_objective_2': 50,\n",
    "    'qa_objective_3': 50,\n",
    "    'nli': 50,\n",
    "    'relation_extraction': 50,\n",
    "    \"summarization\": 42,\n",
    "    \"generation\": 50,\n",
    "    'alternative_diet': 50,\n",
    "    'daily_diets': 50,\n",
    "}\n",
    "default_sample_limit = 50  # ë‚˜ë¨¸ì§€ taskëŠ” 100ê°œì”© ìƒ˜í”Œë§\n",
    "\n",
    "# 4. taskë³„ ìƒ˜í”Œë§ ë°ì´í„° ì´ˆê¸°í™”\n",
    "task_sampled_data = {}\n",
    "# task_countsë¥¼ task_sample_limitsë¡œ ì´ˆê¸°í™”\n",
    "task_counts = {task: 0 for task in task_sample_limits}\n",
    "\n",
    "# 5. Taskë³„ ìƒ˜í”Œë§\n",
    "# í…ŒìŠ¤íŠ¸ ë°ì´í„°ì…‹ì„ ì…”í”Œë§í•˜ì—¬ ëžœë¤ ìƒ˜í”Œë§ ë³´ìž¥\n",
    "test_dataset = test_dataset.shuffle(seed=SEED)\n",
    "\n",
    "for row in test_dataset:\n",
    "    task = row[\"task\"]\n",
    "    dataset_value = row.get(\"dataset\")  # dataset ì»¬ëŸ¼ ê°’ í™•ì¸\n",
    "    input_output_pair = (row[\"input\"], row[\"output\"])\n",
    "\n",
    "    # qa_objective ì„¸ë¶„í™”\n",
    "    if task == \"qa_objective\":\n",
    "        if dataset_value == \"medqa\":\n",
    "            task = \"qa_objective_1\"  # medqaë¡œ ì„¸ë¶„í™”\n",
    "        elif dataset_value == \"medmcqa\":\n",
    "            task = \"qa_objective_2\"  # medmcqaë¡œ ì„¸ë¶„í™”\n",
    "        else:\n",
    "            continue  # medqa, medmcqaê°€ ì•„ë‹ˆë©´ ê±´ë„ˆë›°ê¸°\n",
    "\n",
    "    # í•´ë‹¹ taskì˜ ìƒ˜í”Œë§ ì œí•œ í™•ì¸\n",
    "    sample_limit = task_sample_limits.get(task, default_sample_limit)\n",
    "\n",
    "    # ìƒ˜í”Œë§ ì¡°ê±´ í™•ì¸\n",
    "    if task_counts.get(task, 0) < sample_limit and input_output_pair not in train_pairs:\n",
    "        if task not in task_sampled_data:\n",
    "            task_sampled_data[task] = []\n",
    "        task_sampled_data[task].append(row)\n",
    "        task_counts[task] += 1\n",
    "\n",
    "    # ëª¨ë“  taskì˜ ìƒ˜í”Œë§ì´ ì™„ë£Œë˜ë©´ ì¢…ë£Œ\n",
    "    if all(task_counts.get(task, 0) >= task_sample_limits.get(task, default_sample_limit) for task in task_sample_limits):\n",
    "        break\n",
    "\n",
    "# 6. ê²°ê³¼ ì¶œë ¥ ë° í™•ì¸\n",
    "for task, samples in task_sampled_data.items():\n",
    "    print(f\"Task: {task}, Sampled: {len(samples)}\")\n",
    "    for sample in samples[:5]:  # ì²« 5ê°œ ìƒ˜í”Œë§Œ ì¶œë ¥\n",
    "        print(sample)\n",
    "\n",
    "# 7. í•„ìš” ì‹œ ìƒ˜í”Œë§ëœ ë°ì´í„° ì €ìž¥\n",
    "# pandasë¥¼ ì‚¬ìš©í•˜ì—¬ ë¦¬ìŠ¤íŠ¸ì˜ ë”•ì…”ë„ˆë¦¬ë¥¼ ë°ì´í„°í”„ë ˆìž„ìœ¼ë¡œ ë³€í™˜ í›„ Datasetìœ¼ë¡œ ë³€í™˜\n",
    "sampled_dataset = DatasetDict({\n",
    "    task: Dataset.from_pandas(pd.DataFrame(samples)) for task, samples in task_sampled_data.items()\n",
    "})\n",
    "\n",
    "# ì €ìž¥ (í•„ìš”ì‹œ ì£¼ì„ ì œê±°)\n",
    "# sampled_dataset.save_to_disk(\"sampled_test_dataset\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Task: ned, Sampled: 50\n",
      "{'dataset': 'medal', 'split_data': 'test', 'task': 'ned', 'instruction': 'Identify the expanded version of the given biomedical abbreviation.', 'input': 'Biomedical Term: TLE \\nContext: with the rise in use of assisted reproductive technologies arts there has been an increased awareness of potential genetic problems that may be initiated or propagated using these techniques several population studies have suggested a small but significantly increased risk of imprinting disorders like angelman syndrome beckwithwiedemann syndrome and possibly transient neonatal diabetes in children born through arts although the absolute risk appears to be very small this association logically leads to the question of how arts affect gene imprinting studies investigating SC medias timing of embryassociation T0 in a population of patients with mesial TLE tle with hippocampal sclerosis mtehs together with a systematic revision of the literature to investigate the role of transcriptionally less active polymorphic alleles of prodynorphin pdyn gene in this pathology we included patients with a diagnosis of mtehs and healthy controls the positive antecedent of family history for epileptic events defined a tle subgroup with familial predisposition for epileptic disorders the pdyn promoter polymorphism was genotyped by means of a pcr CA for metaanalysis we identified casecontrol association studies between tle and pdyn by searching pubmed the pooled or was estimated using a fixed effects model under dominant and codominant heredity models no differences in genotypic and allelic frequencies were found between cases and controls p in our population neither in the whole cohort nor in the analysis limited to tle with familial predisposition p the metaanalysis included tle patients and healthy controls we found an association between l S2 p or ic and a modestly higher risk to develop tle in the group of patients with familial predisposition therefore PET allelic SCV in the pdyn promoter might modify the risk to develop tle in subjects with familial predisposition', 'output': 'temporal lobe epilepsy', '__index_level_0__': 34979}\n",
      "{'dataset': 'medal', 'split_data': 'test', 'task': 'ned', 'instruction': 'Identify the expanded version of the given biomedical abbreviation.', 'input': 'Biomedical Term: ACTH \\nContext: we have developed a stressfree therapyÃ‚Â® device wherein pinpoint plantar longwavelength infrared light irradiation pplili increases peripheraldeep body temperature and BFV and stabilizes blood pressure as well as significantly reduces stress hormones such as ACTH hormone and cortisol without using drugs moreover we have found this therapy to significantly improve blood glucose and insulin resistance in patients with type diabetes based on this background of clinical tau we validated changes in CBF blood flow in patients with metabolic cardiovascular disease and examined the tau of stressfree therapyÃ‚Â® on cerebral blood flow as compared to that in healthy control subjects and placebotreated patients', 'output': 'adrenocorticotrophic', '__index_level_0__': 35040}\n",
      "{'dataset': 'medal', 'split_data': 'test', 'task': 'ned', 'instruction': 'Identify the expanded version of the given biomedical abbreviation.', 'input': 'Biomedical Term: DAG \\nContext: insulin resistance is prevalent worldwide and is associated with many metabolic diseases in particular type diabetes mellitus tdm obesity nonalcoholic fatty MLD nafld polycystic ovary syndrome pcos and metabolic syndrome mets angiopoietinlike protein angptl a newlyidentified secreted protein composing of amino acids is enriched in the CL of human considering its promising potential for ÃŽÂ²cell proliferation and there highly connected proteins are predicted to be complexes some propose different clustering algorithms using partitioning overlaps among clusters for networks modeled with unweighted or weighted graphs and others use density of clusters and information based on protein functionality however some schemes still require much processing time or the SQ of their results can be improved furthermore most of the results obtained with computational tools are not accompanied by an analysis of false positives we propose an ERP and efficient mining algorithm for discovering highly connected subgraphs which is our base for defining protein complexes our representation is based on transforming the ppi network into a DAG that reduces the number of represented edges and the search space for discovering subgraphs our RPA considers weighted and unweighted ppi networks we compare our best alternative using ppi networks from saccharomyces cerevisiae yeast and homo sapiens human with stateoftheart approaches in terms of clustering biological metrics and execution times as well as three gold standards for yeast and two for human furthermore we analyze false positive predicted complexes searching the pdbe PDB in europe DB in order to identify matching protein complexes that have been purified and structurally characterized our analysis shows that more than yeast protein complexes and more than human protein complexes found to be false positives according to our prediction method ie not described in the gold standard complex databases in fact contain protein complexes that have been characterized structurally and documented in pdbe we also found that some of these protein complexes have recently been classified as part of a periodic table of protein complexes the latest version of our software is publicly available at httpdoiorgmfigsharev', 'output': 'directed acyclic graph', '__index_level_0__': 34672}\n",
      "{'dataset': 'medal', 'split_data': 'test', 'task': 'ned', 'instruction': 'Identify the expanded version of the given biomedical abbreviation.', 'input': 'Biomedical Term: BC \\nContext: rnase f a guaninespecific ribonuclease from fusarium moniliforme was crystallized in two different forms in the absence of an inhibitor and in the presence of gmp the crystal structure of the rnase f free form was solved by the MR method using the coordinates of the rnase t complex with gmp and was refined to a final rfactor of using the data D2 to a resolution for the crystal structure of the rnase f complex with gmp the solution of the MR method was obtained on the basis of the coordinatse and diabetes VF is also associated with a quartet of metabolic disturbances referred to as the metabolic syndrome these abnormalities include hypertension hyperlipidemia hyperinsulinemia and insulin resistance the metabolic syndrome is also present in cushings syndrome which is characterized by primary hypercortisolism as well as profound visceral adiposity and obesity the interrelationship between hyperactivation or hypersensitivity of the stress axis and disease can be elucidated by an understanding of the effect of excess glucocorticoids upon SE storage and metabolism the complex interactions of the stress axis upon the growth and reproductive axes as well as upon the adipose tissue suggest that chronic stress whether psychological andor physical exerts an intense effect upon BC which in turn significantly affects the longevity and survival of the organism', 'output': 'body composition', '__index_level_0__': 35182}\n",
      "{'dataset': 'medal', 'split_data': 'test', 'task': 'ned', 'instruction': 'Identify the expanded version of the given biomedical abbreviation.', 'input': 'Biomedical Term: MH \\nContext: the myocardial injury that occurs following a period of ischaemia and reperfusion is well recognised and the underlying mechanisms have been extensively investigated in healthy myocardial tissues however the influence of the risk factors associated with cardiovascular diseases on ischaemiareperfusion injury remains unclear in this article the present knowledge on how clinical pathologies such as diabetes hypercholesterolaemia hypertension MH and heart failure may influence ischaemiareperfusion injury of the HR and the potential mechanisms involved are reviewed', 'output': 'myocardial hypertrophy', '__index_level_0__': 34774}\n",
      "Task: qa_objective_3, Sampled: 50\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Is cC genotype at rs12979860 of IL28B associated with lower risk of new-onset diabetes after transplantation in adult patients with liver transplantation for hepatitis C cirrhosis? Context: New-onset diabetes mellitus after transplantation (NODAT) in patients undergoing liver transplantation (LT) for hepatitis C virus (HCV)-related cirrhosis is associated with more aggressive HCV recurrence on the graft, rapid progression of fibrosis, and lower rate of sustained viral response to antiviral therapy. The CC genotype at rs12979860 of the IL28B is associated with greater rates of spontaneous clearance of HCV and response to antiviral therapy. IL28B acts on the interferon-stimulated genes through the JAK-STAT pathway, which is related to the development of insulin resistance. The aim of this study was to investigate whether IL28B rs12979860 polymorphism is associated with the development of NODAT after LT for cirrhosis owing to HCV infection. We analyzed 99 patients (age, 52.7 Â± 9.4 years; 70% male) who underwent LT for HCV-related cirrhosis, with â‰¥1 year of follow-up and with available DNA sample. NODAT was defined starting from the sixth month after LT, according to the international consensus guidelines. Genotyping was carried out by real-time polymerase chain reaction and analysis of the melting temperature with the LightCycler 480 system. Twenty-eight patients (28.3%) developed NODAT. CC genotype at rs12979860 of IL28B was associated with a lesser incidence of NODAT versus non-CC genotypes (P = .05; odds ratio, 0.31; 95% CI, 0.11-0.92). We did not find any association between NODAT and age at transplantation, gender, pretransplant body mass index, presence of hepatocellular carcinoma, type of initial immunosuppression (cyclosporine, tacrolimus or corticosteroids) or acute rejection treated with steroids.', 'output': 'yes', '__index_level_0__': 35870}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Is coronary vasoreactivity altered in young people with type 1 diabetes? Context: Abnormal coronary microvascular circulation has been demonstrated in diabetes and is associated with increased rate of cardiovascular events. Our objective was to evaluate coronary vasoreactivity in young people with type 1 diabetes with and without microvascular complications. Twenty-five type 1 diabetic patients without microvascular complications (DC-), 23 with microvascular complications (DC+), and 18 control subjects (C) were studied. Coronary vasoreactivity was assessed by means of coronary flow reserve (CFR). Blood flow velocity in the left anterior descending coronary artery was measured at rest and after high-dose dipyridamole using transthoracic color-guided pulsed Doppler echocardiography. CFR was defined as the ratio of hyperaemic to resting diastolic peak flow velocities. The three groups had similar cardiac function parameters, and also systolic and diastolic blood pressure at rest, which remained unchanged during dipyridamole infusion. Resting coronary flow velocity was comparable in C, DC-, and DC+ (p=ns). Dipyridamole infusion produced a threefold increase in coronary diastolic peak velocity, which reached similar values in C (0.69Â±0.16 m/s), DC- (0.69Â±0.18 m/s), and DC+ (0.66Â±0.11 m/s). Mean CFR ratio was similar in C (3.33Â±0.66), DC- (3.30Â±0.51), and DC+ (3.24Â±0.60). At multiple linear regression analysis, no association was found between CFR and age, sex, HbA(1c), duration of diabetes, and complications.', 'output': 'no', '__index_level_0__': 35882}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Is relative leg length associated with type 2 diabetes differently according to pubertal timing : the Brazilian longitudinal study of adult health? Context: Studies from developed societies have shown that individuals with short legs relative to height have higher risk of type 2 diabetes. This has been much less explored in less developed populations where influences on relative leg length and diabetes may differ. The Brazilian Longitudinal Study of Adult Health (in Portuguese, ELSA-Brasil) allows us to test, in a cohort born (1934-1975) and raised when undernutrition was common, whether short legs relative to height is positively associated with diabetes, independent of early-life factors, including birth weight, age at menarche, and young-adult BMI. We used baseline, cross-sectional data from 15,105 participants aged 35-74 years participating in ELSA-Brasil. We created age-and-sex-specific Z scores for leg length index (leg length/height Ã— 100) according to an external reference. Diabetes was defined by self-reported physician diagnosis, medication use, fasting and 2-h post-75-g-load glucose, and A1C. A one-unit decrement in leg-length-index Z score was associated with 12% (8-17%) higher prevalence of diabetes in Brazilian adults, after adjustment through Poisson regression for confounders, including race, maternal education, and birth weight. This association persisted after further adjustment for menarche age, BMI (at age 20), buttocks circumference, and waist circumference. It was stronger among women with early menarche (P interaction\\u2009=\\u20090.02). Leg length index was also inversely associated with fasting glucose, fasting insulin, 2-h glucose, and A1C (P\\u2009<\\u20090.05).', 'output': 'yes', '__index_level_0__': 35596}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': \"Question: Is low frequency of toothbrushing practices an independent risk factor for diabetes mellitus in male and dyslipidemia in female : A large-scale , 5-year cohort study in Japan? Context: We previously reported the association between toothbrushing practices and diabetes mellitus (DM) and dyslipidemia (DL) in a cross-sectional study. This study was conducted to clarify whether low frequency of toothbrushing practices is an independent risk factor for DM and DL using a follow-up design. This study was a 5-year retrospective cohort study at St. Luke's International Hospital, Tokyo, Japan. We analyzed study subjects between 30 and 85 years old in 2004, who underwent annual medical examination both in 2004 and 2009. We compared the cumulative incidences of developing DM, DL, hypertension (HT), and hyperuricemia (HUA) between 2004 and 2009 among 3 groups: toothbrushing practices 'after every meal,' 'at least once a day,' and 'less than once a day'. Furthermore, we analyzed odds ratios (ORs) of risk for developing DM and DL by sex after making adjustments for age, obesity, DM, DL, HT, and HUA between two groups: 'after every meal' and 'not after every meal.' The number of study subjects was 13,070. Of 13,070 study subjects, 575 had DM, 5118 had DL, 2599 had HT, and 1908 had HUA in 2004. We excluded the subjects with each disease in 2004. The cumulative incidences (rates) of DM, DL, HT, and HUA between 2004 and 2009 were 318 (2.5%), 1454 (18.3%), 1108 (10.6%), and 489 (4.4%), respectively. Toothbrushing practices 'not after every meal' was a significant risk factor for developing DM in male [OR: 1.43; 95% confidence interval (CI), 1.040-1.970] and developing DL in female (OR: 1.18; 95% CI, 1.004-1.383) compared with toothbrushing practices 'after every meal.'\", 'output': 'yes', '__index_level_0__': 35564}\n",
      "{'dataset': 'pubmedqa', 'split_data': 'test', 'task': 'qa_objective_3', 'instruction': 'Choose the correct anser (Yes, No, or Maybe) for the given question based on the proviced context.', 'input': 'Question: Is the ratio of estimated average glucose to fasting plasma glucose level superior to glycated albumin , hemoglobin A1c , fructosamine , and GA/A1c ratio for assessing Î²-cell function in childhood diabetes? Context: This study investigated the use of the estimated average glucose to fasting plasma glucose ratio (eAG/fPG ratio) to screen for Î²-cell function in pediatric diabetes. Glycated hemoglobin (HbA1c), glycated albumin (GA), fructosamine, insulin, and C-peptide levels were measured. The ratio of GA to HbA1c (GA/A1c ratio) was calculated, and the homeostasis model assessment of Î²-cell function (HOMA-Î²) was determined. Median values of C-peptide, insulin, and HOMA-Î² levels were significantly higher in patients with an increased eAG/fPG ratio than in those with a decreased eAG/fPG ratio. C-peptide and HOMA-Î² levels were more closely correlated with the eAG/fPG ratio than with GA, HbA1c, the GA/A1c ratio, and fructosamine. In contrast, body mass index was significantly associated with GA, GA/A1c ratio, and fructosamine, but not with the eAG/fPG ratio and HbA1c levels. To test the diagnostic accuracies of the eAG/fPG ratio for identifying HOMA-Î²>30.0% in patients with type 2 diabetes, the area under the ROC curve of the eAG/fPG ratio was significantly larger than that of the GA/A1c ratio [0.877 (95% CI, 0.780-0.942) versus 0.775 (95% CI, 0.664-0.865), P=0.039].', 'output': 'yes', '__index_level_0__': 35865}\n",
      "Task: nli, Sampled: 43\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] The influence of contractile activity, insulin, catecholamines and diabetes mellitus on the acute as well as long-term regulation of glucose transport into skeletal muscle was investigated. In Paper I, glucose uptake was determined in the perfused hindlimb preparation; in Papers II-VI the glucose transport process was studied independently of glucose metabolism by determining the uptake of the non-metabolizable glucose analogue 3-O-methylglucose into isolated rat epitrochlearis muscles. The main findings are: Acute regulation of muscle glucose transport: 1. Muscle contraction-induced glucose uptake does not require the presence of insulin. 2. Exercise and a maximal insulin stimulus have additive effects on glucose transport. 3. Catecholamines decrease non-insulin-mediated glucose transport in the absence of albumin, whereas in the presence of albumin an enhancement occurs. 4. The effects of catecholamines are abolished during beta-adrenergic blockade, but remain unaffected during alpha-adrenergic blockade. Long-term regulation of muscle glucose transport: 5. The rat epitrochlearis muscle, a thin, predominantly fast-twitch muscle of the forearm, was shown to be a suitable preparation for the study of factors regulating glucose transport capacity on a long-term basis, since it maintains energy stores and tissue oxygenation for periods of at least 14 h. 6. Sustained insulin deficiency results in marked decreases in basal (40-45%), contraction-induced (50-60%), and insulin-stimulated (65-70%) glucose transport into rat epitrochlearis muscle. 7. The decreased contraction-induced glucose transport capacity can be prevented by frequent exercise during the period of insulin deficiency. 8. The decreased insulin responsiveness of the muscle glucose transport system can be reversed either by treating previously untreated diabetic rats with insulin or by in vitro incubation of the muscles for 12-14 hours. 9. The in vitro normalization of the insulin-stimulated glucose transport capacity (a) does not require the presence of serum or insulin, (b) occurs despite high (30 mM) concentrations of glucose, (c) is incomplete in the presence of diabetic serum and (d) is blocked to the amount of 30-80% in the presence of protein synthesis inhibition.', 'output': 'entailment', '__index_level_0__': 34403}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Most insulin is secreted in discrete pulses at an interval of approximately 6 min. Increased insulin secretion after meal ingestion is achieved through the mechanism of amplification of the burst mass. Conversely, in type 2 diabetes, insulin secretion is impaired as a consequence of decreased insulin pulse mass. beta-cell mass is reported to be deficient in type 2 diabetes. We tested the hypothesis that decreased beta-cell mass leads to decreased insulin pulse mass. Insulin secretion was examined before and after an approximately 60% decrease in beta-cell mass achieved by a single injection of alloxan in a porcine model. Alloxan injection resulted in stable diabetes (fasting plasma glucose 7.4 +/- 1.1 vs. 4.4 +/- 0.1 mmol/l; P < 0.01) with impaired insulin secretion in the fasting and fed states and during a hyperglycemic clamp (decreased by 54, 80, and 90%, respectively). Deconvolution analysis revealed a selective decrease in insulin pulse mass (by 54, 60, and 90%) with no change in pulse frequency. Rhythm analysis revealed no change in the periodicity of regular oscillations after alloxan administration in the fasting state but was unable to detect stable rhythms reliably after enteric or intravenous glucose stimulation. After alloxan administration, insulin secretion and insulin pulse mass (but not insulin pulse interval) decreased in relation to beta-cell mass. However, the decreased pulse mass (and pulse amplitude delivered to the liver) was associated with a decrease in hepatic insulin clearance, which partially offset the decreased insulin secretion. Despite hyperglycemia, postprandial glucagon concentrations were increased after alloxan administration (103.4 +/- 6.3 vs. 92.2 +/- 2.5 pg/ml; P < 0.01).', 'output': 'contradiction', '__index_level_0__': 34443}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Diabetic vessels undergo structural changes that are linked to a high incidence of cardiovascular diseases. Reactive oxygen species (ROS) mediate cell signalling in the vasculature, where they can promote cell growth and activate redox-regulated transcription factors, like activator protein-1 (AP-1) or nuclear factor-kappaB (NF-kappaB), which are involved in remodelling and inflammation processes. Amadori adducts, formed through nonenzymatic glycosylation, can contribute to ROS formation in diabetes. In this study, we analysed whether Amadori-modified human oxyhaemoglobin, glycosylated at either normal (N-Hb) or elevated (E-Hb) levels, can induce cell growth and activate AP-1 and NF-kappaB in cultured human aortic smooth muscle cells (HASMC). E-Hb (1 nm-1 x microm), but not N-Hb, promoted a concentration-dependent increase in cell size from nanomolar concentrations, although it failed to stimulate HASMC proliferation. At 10 nm, E-Hb stimulated both AP-1 and NF-kappaB activity, as assessed by transient transfection, electromobility shift assays or immunofluorescence staining. The effects of E-Hb resembled those of the proinflammatory cytokine tumour necrosis factor-alpha (TNF-alpha). E-Hb enhanced intracellular superoxide anions content and its effects on HASMC were abolished by different ROS scavengers.', 'output': 'entailment', '__index_level_0__': 34441}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': \"[PRE] Diabetes mellitus is a major risk factor in the development of atherosclerosis and cardiovascular disease conditions, involving intimal injury and enhanced vascular smooth muscle cell (VSMC) migration. We report a mechanistic basis for divergences between insulin's inhibitory effects on migration of aortic VSMC from control Wistar Kyoto (WKY) rats versus Goto-Kakizaki (GK) diabetic rats. In normal WKY VSMC, insulin increased MAPK phosphatase-1 (MKP-1) expression as well as MKP-1 phosphorylation, which stabilizes it, and inhibited PDGF-mediated MAPK phosphorylation and cell migration. In contrast, basal migration was elevated in GK diabetic VSMCs, and all of insulin's effects on MKP-1 expression and phosphorylation, MAPK phosphorylation, and PDGF-stimulated migration were markedly inhibited. The critical importance of MKP-1 in insulin inhibition of VSMC migration was evident from several observations. MKP-1 small interfering RNA inhibited MKP-1 expression and abolished insulin inhibition of PDGF-induced VSMC migration. Conversely, adenoviral expression of MKP-1 decreased MAPK phosphorylation and basal migration rate and restored insulin's ability to inhibit PDGF-directed migration in GK diabetic VSMCs. Also, the proteasomal inhibitors lactacystin and MG132 partially restored MKP-1 protein levels in GK diabetic VSMCs and inhibited their migration. Furthermore, GK diabetic aortic VSMCs had reduced cGMP-dependent protein kinase Ialpha (cGK Ialpha) levels as well as insulin-dependent, but not sodium nitroprusside-dependent, stimulation of cGMP. Adenoviral expression of cGK Ialpha enhanced MKP-1 inhibition of MAPK phosphorylation and VSMC migration.\", 'output': 'contradiction', '__index_level_0__': 34424}\n",
      "{'dataset': 'bionli', 'split_data': 'test', 'task': 'nli', 'instruction': 'Please classify the relationship between the given premise and hypothesis into one of the following labels: entailment, contradiction, or neutral. return only the label.', 'input': '[PRE] Endothelial progenitor cells (EPCs) are thought to be important for maintaining normal vascular function. We conducted a prospective study evaluating the effect of the erythropoiesis-stimulating agent darbepoetin alfa on EPCs and vascular function in patients with chronic kidney disease (CKD), with or without diabetes. Thirty subjects with CKD (20 subjects with type II diabetes mellitus and 10 without diabetes mellitus) received weekly subcutaneous administration of darbepoetin alfa for 4 weeks. EPCs were measured at baseline and 2 and 4 weeks after drug administration. Vascular function was measured with brachial ultrasound and cell activity was measured with a cell proliferation assay. Cells expressing CD133, CD34, CD146 and CD146/31 were significantly elevated (all p < 0.05), flow-mediated vasodilatation increased 2.1%, 95% CI: (0.4%, 3.8%) and colony-forming units increased twofold, 95% CI: (1.7, 2.3) after 4 weeks of treatment with darbepoetin alfa. Subjects with diabetes exhibited an increase in a subset of EPCs (CD133( +) and 34(+), p < 0.01 and p = 0.06, respectively), vasodilatation and proliferation.', 'output': 'entailment', '__index_level_0__': 34429}\n",
      "Task: qa_objective_2, Sampled: 50\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 60-year-old man with diabetes acutely develops double vision and discomfort in his left eye. On examination, there is ptosis of the left eyelid, the eye is rotated down and out, and the pupil is 3 mm and reactive to light. The right eye is normal. Which of the following is the most likely diagnosis? Please select one of the following: A) fourth nerve palsy, B) diabetic autonomic neuropathy, C) third nerve palsy, D) sixth nerve palsy.', 'output': 'C) third nerve palsy', '__index_level_0__': 35312}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A patient with polyuria and polydipsia is newly diagnosed with central diabetes insipidus (DI). Which of the following is the most likely finding on magnetic resonance imaging (MRI) of the brain? Please select one of the following: A) hypothalamic tumor, B) hyperintense signals in the cerebral cortex, C) agenesis of the corpus callosum, D) lack of hyperintense signals from the posterior pituitary.', 'output': 'D) lack of hyperintense signals from the posterior pituitary', '__index_level_0__': 35251}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'True about diabetes in pregnancy are all except Please select one of the following: A) Glucose challenge test is done between 24-28 weeks, B) 50gm of sugar is taken for screening test, C) Insulin resistance improves with pregnancy, D) Diabetes control before conception is impoant to prevent malformations.', 'output': 'C) Insulin resistance improves with pregnancy', '__index_level_0__': 35328}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': \"A 26-year-old gravida 3 woman has a history of gestational diabetes and a delivery of two previous infants at term that were greater than 4000 grams, each of whom had severe hypoglycemia. Which of the following maneuvers is least likely to reduce the chance of the next child's having hypoglycemia? Please select one of the following: A) Careful control of the maternal blood glucose levels during pregnancy, B) Maternal intravenous loading with 10% glucose beginning 2 to 4 h prior to the expected time of delivery, C) Careful glucose monitoring of the infant, D) Early feedings of the infant.\", 'output': 'B) Maternal intravenous loading with 10% glucose beginning 2 to 4 h prior to the expected time of delivery', '__index_level_0__': 35253}\n",
      "{'dataset': 'medmcqa', 'split_data': 'test', 'task': 'qa_objective_2', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 29-year-old woman diagnosed with type 1 diabetes at the age of 12 has poor control. HBA1c is 8.1 %. O/e, the patient has a raised, smooth lump that is firm on palpation at the lower abdomen. The most likely diagnosis is: Please select one of the following: A) Worsening of diabetes, B) Lipohypertrophy, C) Injection scarring, D) Lipoma.', 'output': 'D) Lipoma', '__index_level_0__': 35250}\n",
      "Task: qa_objective_1, Sampled: 50\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 65-year-old woman presents to her physician with a persistent and debilitating cough which began 3 weeks ago, and chest pain accompanied by shortness of breath for the past week. Past medical history is significant for breast carcinoma 10 years ago treated with mastectomy, chemotherapy and radiation, a hospitalization a month ago for pneumonia that was treated with antibiotics, hypertension, and diabetes mellitus. Medications include chlorthalidone and metformin. She does not smoke but her husband has been smoking 3 packs a day for 30 years. Today her respiratory rate is 20/min and the blood pressure is 150/90 mm Hg. Serum Na is 140 mmol/L, serum K is 3.8 mmol/L and serum Ca is 12.2 mg/dL. A chest X-ray (shown in image) is performed. Which of the following is the most likely diagnosis? Please select one of the following: A) Bacterial pneumonia, B) Small cell carcinoma lung, C) Squamous cell carcinoma lung, D) Tuberculosis.', 'output': 'C) Squamous cell carcinoma lung', '__index_level_0__': 35532}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 55-year-old man who recently immigrated to the United States from Azerbaijan comes to the physician because of a 6-week history of recurrent fever, progressive cough with bloody streaks, fatigue, and a 3.6-kg (8-lb) weight loss. He has poorly-controlled type 2 diabetes mellitus treated with insulin. An x-ray of the chest shows a cavitary lesion of the posterior apical segment of the right upper lobe with consolidation of the surrounding parenchyma. He is started on a treatment regimen with a combination of drugs. A culture of the sputum identifies a causal pathogen that is resistant to a drug that alters the metabolism of pyridoxine. Which of the following is the most likely mechanism of resistance to this drug? Please select one of the following: A) Increased production of arabinosyl transferase, B) Impaired conversion to pyrazinoic acid, C) Mutation in genes encoding RNA polymerase, D) Decreased production of catalase-peroxidase.', 'output': 'D) Decreased production of catalase-peroxidase', '__index_level_0__': 35419}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 64-year-old woman presents to the surgical oncology clinic as a new patient for evaluation of recently diagnosed breast cancer. She has a medical history of type 2 diabetes mellitus for which she takes metformin. Her surgical history is a total knee arthroplasty 7 years ago. Her family history is insignificant. Physical examination is notable for an irregular nodule near the surface of her right breast. Her primary concern today is which surgical approach will be chosen to remove her breast cancer. Which of the following procedures involves the removal of a portion of a breast? Please select one of the following: A) Vasectomy, B) Mastectomy, C) Lumpectomy, D) Laminectomy.', 'output': 'C) Lumpectomy', '__index_level_0__': 35369}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 69-year-old man presents for a general follow up appointment. He states that he is doing well and wants to be sure he is healthy. The patientâ€™s past medical history is significant for type II diabetes mellitus, peripheral vascular disease, and hypertension. His current medications include metformin, glyburide, lisinopril, metoprolol and hydrochlorothiazide. His blood pressure is 130/90 mmHg and pulse is 80/min. A fasting lipid panel was performed last week demonstrating an LDL of 85 mg/dL and triglycerides of 160 mg/dL. The patient states that he has not experienced any symptoms since his last visit. The patientâ€™s blood glucose at this visit is 100 mg/dL. Which of the following is recommended in this patient? Please select one of the following: A) Increase lisinopril dose, B) Increase metformin dose, C) Begin statin therapy, D) Discontinue metoprolol and start propranolol.', 'output': 'C) Begin statin therapy', '__index_level_0__': 35514}\n",
      "{'dataset': 'medqa', 'split_data': 'test', 'task': 'qa_objective_1', 'instruction': 'Select the most appropriate answer for the given medical question from the provided options.', 'input': 'A 24-year-old man comes to the physician for a routine health maintenance examination. He feels well. He has type 1 diabetes mellitus. His only medication is insulin. He immigrated from Nepal 2 weeks ago . He lives in a shelter. He has smoked one pack of cigarettes daily for the past 5 years. He has not received any routine childhood vaccinations. The patient appears healthy and well nourished. He is 172 cm (5 ft 8 in) tall and weighs 68 kg (150 lb); BMI is 23 kg/m2. His temperature is 36.8Â°C (98.2Â°F), pulse is 72/min, and blood pressure is 123/82 mm Hg. Examination shows a healed scar over his right femur. The remainder of the examination shows no abnormalities. A purified protein derivative (PPD) skin test is performed. Three days later, an induration of 13 mm is noted. Which of the following is the most appropriate initial step in the management of this patient? Please select one of the following: A) Perform interferon-Î³ release assay, B) Obtain a chest x-ray, C) Administer isoniazid for 9 months, D) Collect sputum sample for culture.', 'output': 'B) Obtain a chest x-ray', '__index_level_0__': 35423}\n",
      "Task: ner, Sampled: 50\n",
      "{'dataset': 'chemdner', 'split_data': 'test', 'task': 'ner', 'instruction': 'List the names of chemicals and drugs that appear in the following biomedical passage related to diabetes.', 'input': 'OBJECTIVE Recent evidence indicates that heat-enhanced food advanced glycation end products (AGEs) adversely affect vascular function. The aim of this study was to examine the acute effects of an oral load of heat-treated, AGE-modified Î²-lactoglobulins (AGE-BLG) compared with heat-treated, nonglycated BLG (C-BLG) on vascular function in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS In a double-blind, controlled, randomized, crossover study, 19 patients with T2DM received, on two different occasions, beverages containing either AGE-BLG or C-BLG. We measured macrovascular [brachial ultrasound of flow-mediated dilatation (FMD)] and microvascular (laser-Doppler measurements of reactive hyperemia in the hand) functions at baseline (T0), 90 (T90), and 180 (T180) min. RESULTS Following the AGE-BLG, FMD decreased at T90 by 80% from baseline and remained decreased by 42% at T180 (P < 0.05 vs. baseline, P < 0.05 vs. C-BLG at T90). By comparison, following C-BLG, FMD decreased by 27% at T90 and 51% at T180 (P < 0.05 vs. baseline at T180). A significant decrease in nitrite (T180) and nitrate (T90 and T180), as well as a significant increase in N(Îµ)-carboxymethyllisine, accompanied intake of AGE-BLG. There was no change in microvascular function caused by either beverage. CONCLUSIONS In patients with T2DM, acute oral administration of a single AGE-modified protein class significantly though transiently impaired macrovascular function in concert with decreased nitric oxide bioavailability. These AGE-related changes were independent of heat treatment.', 'output': 'nitrite, nitrate, N(Îµ)-carboxymethyllisine, nitric oxide', '__index_level_0__': 34568}\n",
      "{'dataset': 'chemdner', 'split_data': 'test', 'task': 'ner', 'instruction': 'List the names of chemicals and drugs that appear in the following biomedical passage related to diabetes.', 'input': 'Metabolic profiling of plasma nonesterified fatty acids discovered that palmitic acid (PA), a natural peroxisome proliferator-activated receptor Î³ (PPARÎ³) ligand, is a reliable type 2 diabetes biomarker. We investigated whether and how PA diabetic (d-PA) concentrations affected endothelial progenitor cell (EPC) and bone marrow-derived hematopoietic cell (BM-HC) biology. PA physiologic (n-PA) and d-PA concentrations were used. Proliferating cell nuclear antigen content and signal transducer and activator of transcription 5 (STAT5), PPARÎ³, cyclin D1, and p21(Waf) expression were evaluated. Small interfering RNA technology, gene reporter luciferase assay, electrophoretic mobility shift assay, chromatin immunoprecipitation assay, and coimmunoprecipitation were exploited. In vivo studies and migration assays were also performed. d-PA, unlike n-PA or physiological and diabetic oleic and stearic acid concentrations, impaired EPC migration and EPC/BM-HC proliferation through a PPARÎ³-mediated STAT5 transcription inhibition. This event did not prevent the formation of a STAT5/PPARÎ³ transcriptional complex but was crucial for gene targeting, as p21(Waf) gene promoter, unlike cyclin D1, was the STAT5/PPARÎ³ transcriptional target. Similar molecular events could be detected in EPCs isolated from type 2 diabetic patients. By expressing a constitutively activated STAT5 form, we demonstrated that STAT5 content is crucial for gene targeting and EPC fate. Finally, we also provide in vivo data that d-PA-mediated EPC dysfunction could be rescued by PPARÎ³ blockade. These data provide first insights on how mechanistically d-PA drives EPC/BM-HC dysfunction in diabetes.', 'output': 'oleic and stearic acid, fatty acids, palmitic acid', '__index_level_0__': 34578}\n",
      "{'dataset': 'chemdner', 'split_data': 'test', 'task': 'ner', 'instruction': 'List the names of chemicals and drugs that appear in the following biomedical passage related to diabetes.', 'input': \"Several persistent organic pollutants are reported to be potentially associated with the risk of human diabetes that has become rapidly epidemic in China currently. 2,2',3,3',4,4',5,5',6,6'-decabromodiphenyl ether (BDE209) is commercially most important both in the production and in the use of polybrominated diphenyl ethers (PBDEs). It might bioaccumulate in wildlife and human and is the only PBDEs mixture still used today. In the present study, male adult rats treated with BDE209 (0, 0.05, 1, and 20\\xa0mg/kg) for 8\\xa0weeks were used to explore the effects of BDE209 on glucose homeostasis and possible mechanisms; 0.05\\xa0mg/kg of BDE209 induced dose-related hyperglycemia. Then, we performed the full-genome gene expression microarrays, gene ontology analysis, and pathway analysis in this group and control. BDE209 induced 1,257 liver gene transcript changes, and 18 canonical pathways were significantly enriched. Four of them were involved in immune diseases, including autoimmune thyroid disease, graft-versus-host disease, allograft rejection, and type I diabetes mellitus (T1MD), which was confirmed by the decrease in serum insulin. Subsequently, gene act network and gene co-expression network found that some MHC molecules and TNF-Î± were involved in T1DM pathway, which was then confirmed by the increase in serum TNF-Î±. Additionally, reduced glutathione and superoxide dismutase in plasma indicated that oxidative damage might partly contribute to BDE209-induced hyperglycemia. The results of this study provide some new experimental evidence that the exposure to high levels of BDE209 may contribute to the onset of diabetes in human populations. Further work needs to be done to confirm this link.\", 'output': \"superoxide, PBDEs, polybrominated diphenyl ethers, glucose, 2,2',3,3',4,4',5,5',6,6'-decabromodiphenyl ether, BDE209, reduced glutathione\", '__index_level_0__': 34549}\n",
      "{'dataset': 'chemdner', 'split_data': 'test', 'task': 'ner', 'instruction': 'List the names of chemicals and drugs that appear in the following biomedical passage related to diabetes.', 'input': 'Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus.', 'output': 'AZD1656', '__index_level_0__': 34561}\n",
      "{'dataset': 'chemdner', 'split_data': 'test', 'task': 'ner', 'instruction': 'List the names of chemicals and drugs that appear in the following biomedical passage related to diabetes.', 'input': 'AIMS/HYPOTHESIS: PPARGC1A and PPARGC1B encode transcriptional coactivators that regulate numerous type 2 diabetes-related metabolic processes. Common genetic variation across PPARGC1A/B was characterised by genotyping tagging variants. We then tested associations of these variants with diabetes incidence or change in quantifiable metabolic traits directly or via interactions (with metformin treatment or intensive lifestyle modification) in the Diabetes Prevention Program (DPP), a randomised controlled trial in persons at high risk of type 2 diabetes. METHODS: We used Tagger software to select 75 PPARGC1A and 94 PPARGC1B tag single nucleotide polymorphisms (SNPs) for analysis. These SNPs were tested for association with diabetes incidence using Cox proportional hazards regression models, and a range of relevant metabolic quantifiable traits, using generalised linear models. RESULTS: Eight PPARGC1A variants were nominally (p\\u2009<\\u20090.05) associated with diabetes incidence, of which one (rs3736265/Thr612Met) was associated with diabetes in the DPP (HR 1.31, 95% CI 1.05, 1.63 per copy of the 612Met allele) and in the DIAGRAM database (OR 1.11, 95% CI 1.01, 1.21). Consistent with earlier reports, the Gly482Ser (rs8192678) variant showed nominally significant effects on 1\\xa0year accumulation of adiposity and worsening insulin resistance (both p\\u2009<\\u20090.05). A third PPARGC1A variant (rs2970852) modified the effects of metformin on triacylglycerol levels (p interaction\\u2009=\\u20090.04; p\\u2009=\\u20090.0001 for association of SNP with triacylglycerol concentrations in metformin-treated participants). A number of other PPARGC1A/B variants were nominally directly associated with diabetes incidence or modified treatment effects on diabetes incidence. CONCLUSIONS/INTERPRETATION: These findings provide some novel and confirmatory insights into the roles of PPARGC1A/B variation in type 2 diabetes and related metabolic traits. TRIAL REGISTRATION: ClinicalTrials.gov NCT00004992.', 'output': 'triacylglycerol, Met, metformin', '__index_level_0__': 34554}\n"
     ]
    }
   ],
   "source": [
    "import random\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "from datasets import load_dataset, Dataset, DatasetDict\n",
    "\n",
    "# âœ… ì‹œë“œ ì„¤ì •\n",
    "SEED = 42\n",
    "random.seed(SEED)\n",
    "np.random.seed(SEED)\n",
    "\n",
    "# âœ… 1. ë°ì´í„°ì…‹ ë¡œë“œ\n",
    "dataset_name = \"passionMan/diabetes_v9\"\n",
    "train_dataset = load_dataset(dataset_name, split=\"train\")\n",
    "test_dataset = load_dataset(dataset_name, split=\"test\")\n",
    "\n",
    "# âœ… 2. ì¤‘ë³µ ë°©ì§€ë¥¼ ìœ„í•œ (input, output) ì„¸íŠ¸ ìƒì„±\n",
    "train_pairs = set((row[\"input\"], row[\"output\"]) for row in train_dataset)\n",
    "\n",
    "# âœ… 3. `qa`, `ner`, `nli`, `ned`ë§Œ ìƒ˜í”Œë§ ëŒ€ìƒ\n",
    "task_sample_limits = {\n",
    "    'qa_objective_1': 50,  # medqa\n",
    "    'qa_objective_2': 50,  # medmcqa\n",
    "    'qa_objective_3': 50,  # pubmedqa\n",
    "    'nli': 50,\n",
    "    'ner': 50,\n",
    "    'ned': 50,\n",
    "}\n",
    "default_sample_limit = 50  # ê¸°ë³¸ê°’ 50ê°œ ìƒ˜í”Œë§\n",
    "\n",
    "# âœ… 4. ìƒ˜í”Œë§ ë°ì´í„° ì €ìž¥ìš© ë”•ì…”ë„ˆë¦¬ ì´ˆê¸°í™”\n",
    "task_sampled_data = {}\n",
    "task_counts = {task: 0 for task in task_sample_limits}  # âœ… í•„ìš” taskë§Œ ì´ˆê¸°í™”\n",
    "\n",
    "# âœ… 5. Taskë³„ ìƒ˜í”Œë§ ìˆ˜í–‰\n",
    "test_dataset = test_dataset.shuffle(seed=SEED)\n",
    "\n",
    "for row in test_dataset:\n",
    "    task = row[\"task\"]\n",
    "    dataset_value = row.get(\"dataset\")  # âœ… dataset ì»¬ëŸ¼ ê°’ í™•ì¸\n",
    "    input_output_pair = (row[\"input\"], row[\"output\"])\n",
    "\n",
    "    # âœ… 5-1. `qa_objective`ë¥¼ `medqa`ì™€ `medmcqa`ë¡œ ì„¸ë¶„í™”\n",
    "    if task == \"qa_objective\":\n",
    "        if dataset_value == \"medqa\":\n",
    "            task = \"qa_objective_1\"  # medqa\n",
    "        elif dataset_value == \"medmcqa\":\n",
    "            task = \"qa_objective_2\"  # medmcqa\n",
    "        elif dataset_value == \"pubmedqa\":\n",
    "            task = \"qa_objective_3\"  # pubmedqa\n",
    "        else:\n",
    "            continue  # âœ… `medqa`, `medmcqa`, `pubmedqa`ê°€ ì•„ë‹ˆë©´ ê±´ë„ˆë›°ê¸°\n",
    "\n",
    "    # âœ… 5-2. `qa`, `ner`, `nli`, `ned` ì™¸ì˜ taskëŠ” ë¬´ì‹œ\n",
    "    if task not in task_sample_limits:\n",
    "        continue  # âœ… í•„ìš” ì—†ëŠ” taskëŠ” ìƒ˜í”Œë§ ëŒ€ìƒì—ì„œ ì œì™¸\n",
    "\n",
    "    # âœ… 5-3. ìƒ˜í”Œë§ ê°œìˆ˜ í™•ì¸ ë° ì¤‘ë³µ ë°©ì§€\n",
    "    sample_limit = task_sample_limits.get(task, default_sample_limit)\n",
    "    \n",
    "    if task_counts.get(task, 0) < sample_limit and input_output_pair not in train_pairs:\n",
    "        if task not in task_sampled_data:\n",
    "            task_sampled_data[task] = []\n",
    "        task_sampled_data[task].append(row)\n",
    "        task_counts[task] += 1\n",
    "\n",
    "    # âœ… 5-4. ëª¨ë“  taskì˜ ìƒ˜í”Œë§ ê°œìˆ˜ê°€ ì¶©ì¡±ë˜ë©´ ì¢…ë£Œ\n",
    "    if all(task_counts.get(task, 0) >= task_sample_limits.get(task, default_sample_limit) for task in task_sample_limits):\n",
    "        break\n",
    "\n",
    "# âœ… 6. ìƒ˜í”Œë§ ê²°ê³¼ ì¶œë ¥ (ê° taskë³„ 5ê°œ ìƒ˜í”Œ í™•ì¸)\n",
    "for task, samples in task_sampled_data.items():\n",
    "    print(f\"Task: {task}, Sampled: {len(samples)}\")\n",
    "    for sample in samples[:5]:  \n",
    "        print(sample)\n",
    "\n",
    "# âœ… 7. ìƒ˜í”Œë§ëœ ë°ì´í„° DatasetDictë¡œ ë³€í™˜\n",
    "sampled_dataset = DatasetDict({\n",
    "    task: Dataset.from_pandas(pd.DataFrame(samples)) for task, samples in task_sampled_data.items()\n",
    "})\n",
    "\n",
    "# âœ… 8. í•„ìš”í•˜ë©´ ì €ìž¥ ê°€ëŠ¥ (ì£¼ì„ í•´ì œ)\n",
    "# sampled_dataset.save_to_disk(\"sampled_test_dataset\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing samples: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 434/434 [2:10:18<00:00, 18.01s/sample]    \n"
     ]
    },
    {
     "ename": "",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31mThe Kernel crashed while executing code in the current cell or a previous cell. \n",
      "\u001b[1;31mPlease review the code in the cell(s) to identify a possible cause of the failure. \n",
      "\u001b[1;31mClick <a href='https://aka.ms/vscodeJupyterKernelCrash'>here</a> for more info. \n",
      "\u001b[1;31mView Jupyter <a href='command:jupyter.viewOutput'>log</a> for further details."
     ]
    }
   ],
   "source": [
    "import json\n",
    "import re\n",
    "from tqdm import tqdm\n",
    "from transformers import TextStreamer\n",
    "\n",
    "FastLanguageModel.for_inference(model)\n",
    "\n",
    "output_file = \"inference_results_0130.jsonl\"\n",
    "\n",
    "# 1. `tqdm`ì„ ì‚¬ìš©í•˜ì—¬ ì§„í–‰ ìƒíƒœ í‘œì‹œ\n",
    "total_samples = sum(len(samples) for samples in sampled_dataset.values())\n",
    "with open(output_file, 'w') as f_out:\n",
    "    with tqdm(total=total_samples, desc=\"Processing samples\", unit=\"sample\") as pbar:\n",
    "        for task, sample in sampled_dataset.items():\n",
    "            for samp in sample:\n",
    "                # ë°ì´í„°ì…‹ ì´ë¦„ì— ë”°ë¥¸ context length ì„¤ì •\n",
    "                dataset_name = samp.get(\"dataset\", \"\")\n",
    "                max_new_tokens = 8192 if dataset_name in [\"pubmedqa\", \"pubmed\", \"icliniq\"] else 2048\n",
    "\n",
    "                # ìž…ë ¥ í† í° ìƒì„±\n",
    "                inputs = tokenizer(\n",
    "                    [\n",
    "                        alpaca_prompt.format(\n",
    "                            samp['instruction'],  # instruction\n",
    "                            samp['input'],  # input\n",
    "                            \"\",  # output\n",
    "                        )\n",
    "                    ], return_tensors=\"pt\"\n",
    "                ).to(\"cuda\")\n",
    "\n",
    "                # TextStreamer ì„¤ì •\n",
    "                text_streamer = TextStreamer(tokenizer)\n",
    "                \n",
    "                # ëª¨ë¸ ìƒì„± ë° ì¶œë ¥\n",
    "                output_tensor = model.generate(\n",
    "                    **inputs, \n",
    "                    max_new_tokens=max_new_tokens\n",
    "                )\n",
    "                model_output = tokenizer.decode(output_tensor[0], skip_special_tokens=True)\n",
    "\n",
    "                # `### Response:` ë’¤ì˜ í…ìŠ¤íŠ¸ ì¶”ì¶œ\n",
    "                response_text = None\n",
    "                response_match = re.search(r\"### Response:\\s*(.+)\", model_output, re.DOTALL)\n",
    "                if response_match:\n",
    "                    response_text = response_match.group(1).strip()\n",
    "                else:\n",
    "                    response_text = \"No valid response found\"\n",
    "\n",
    "                # ëª¨ë¸ ì¶œë ¥ ê²°ê³¼ë¥¼ sampì— ì¶”ê°€\n",
    "                samp['model_output'] = response_text\n",
    "\n",
    "                # JSONL í˜•ì‹ìœ¼ë¡œ ì €ìž¥\n",
    "                f_out.write(json.dumps(samp, ensure_ascii=False) + \"\\n\")\n",
    "                \n",
    "                # tqdm ì§„í–‰ ìƒíƒœ ì—…ë°ì´íŠ¸\n",
    "                pbar.update(1)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "meal_kernel",
   "language": "python",
   "name": "meal"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
